Exact Mass: 540.2768306

Exact Mass Matches: 540.2768306

Found 500 metabolites which its exact mass value is equals to given mass value 540.2768306, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Condurangogenin C

Condurangogenin C

C32H44O7 (540.3086874)


   

KA-5685

4-Deamino-4-hydroxyapramycin

C21H40N4O12 (540.26426)


   

Ciclesonide

2-[(1S,2S,4R,8S,9S,11S,12S,13R)-6-cyclohexyl-11-hydroxy-9,13-dimethyl-16-oxo-5,7-dioxapentacyclo[10.8.0.0^{2,9}.0^{4,8}.0^{13,18}]icosa-14,17-dien-8-yl]-2-oxoethyl 2-methylpropanoate

C32H44O7 (540.3086874)


R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03B - Other drugs for obstructive airway diseases, inhalants > R03BA - Glucocorticoids R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use > R01AD - Corticosteroids D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones > D005938 - Glucocorticoids COVID info from Guide to PHARMACOLOGY, clinicaltrial, clinicaltrials, clinical trial, clinical trials C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone C308 - Immunotherapeutic Agent > C574 - Immunosuppressant > C211 - Therapeutic Corticosteroid D018926 - Anti-Allergic Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

Ciclesonide

2-[(1S,2S,4R,8S,9S,11S,12S,13R)-6-cyclohexyl-11-hydroxy-9,13-dimethyl-16-oxo-5,7-dioxapentacyclo[10.8.0.0^{2,9}.0^{4,8}.0^{13,18}]icosa-14,17-dien-8-yl]-2-oxoethyl 2-methylpropanoate

C32H44O7 (540.3086874)


Ciclesonide is only found in individuals that have used or taken this drug. It is a glucocorticoid used to treat obstructive airway diseases. It is marketed under the brand name Alvesco.Glucocorticoids such as ciclesonide can inhibit leukocyte infiltration at the site of inflammation, interfere with mediators of inflammatory response, and suppress humoral immune responses. The antiinflammatory actions of glucocorticoids are thought to involve phospholipase A2 inhibitory proteins, lipocortins, which control the biosynthesis of potent mediators of inflammation such as prostaglandins and leukotrienes. Ciclesonide reduces inflammatory reaction by limiting the capillary dilatation and permeability of the vascular structures. These compounds restrict the accumulation of polymorphonuclear leukocytes and macrophages and reduce the release of vasoactive kinins. Recent research suggests that corticosteroids may inhibit the release of arachidonic acid from phospholipids, thereby reducing the formation of prostaglandins. Ciclesonide is a glucocorticoid receptor agonist. On binding, the corticoreceptor-ligand complex translocates itself into the cell nucleus, where it binds to many glucocorticoid response elements (GRE) in the promoter region of the target genes. The DNA bound receptor then interacts with basic transcription factors, causing an increase or decrease in expression of specific target genes, including suppression of IL2 (interleukin 2) expression.

   

Tetrahydroaldosterone-3-glucuronide

(2S,3S,4R,5R,6R)-3,4,5-trihydroxy-6-{[(2S,14S,16S)-18-hydroxy-2-(2-hydroxyacetyl)-14-methyl-17-oxapentacyclo[14.2.1.0¹,⁵.0⁶,¹⁵.0⁹,¹⁴]nonadecan-11-yl]oxy}oxane-2-carboxylic acid

C27H40O11 (540.257049)


Tetrahydroaldosterone-3-glucuronide is a natural human metabolite of Tetrahydroaldosterone generated in the liver by UDP glucuonyltransferase. Glucuronidation is used to assist in the excretion of toxic substances, drugs or other substances that cannot be used as an energy source. Glucuronic acid is attached via a glycosidic bond to the substance, and the resulting glucuronide, which has a much higher water solubility than the original substance, is eventually excreted by the kidneys. Tetrahydroaldosterone-3-glucuronide is a natural human metabolite of Tetrahydroaldosterone generated in the liver by UDP glucuonyltransferase. D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

   

Atorvastatin lactone

5-(4-fluorophenyl)-1-[2-(4-hydroxy-6-oxooxan-2-yl)ethyl]-N,4-diphenyl-2-(propan-2-yl)-1H-pyrrole-3-carboxamide

C33H33FN2O4 (540.242423)


   

PA(2:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4))

[(2R)-3-(acetyloxy)-2-{[(5Z,7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoyl]oxy}propoxy]phosphonic acid

C27H41O9P (540.2488066)


PA(2:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(2:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4)), in particular, consists of one chain of one acetyl at the C-1 position and one chain of 4-hydroxy-docosahexaenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

   

PA(2:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7))

[(2R)-2-(acetyloxy)-3-{[(5Z,7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoyl]oxy}propoxy]phosphonic acid

C27H41O9P (540.2488066)


PA(2:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(2:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)), in particular, consists of one chain of one acetyl at the C-1 position and one chain of 7-hydroxy-docosahexaenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

   

PA(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/2:0)

[(2R)-2-(acetyloxy)-3-{[(4Z,8Z,10Z,13Z,16Z,19Z)-7-hydroxydocosa-4,8,10,13,16,19-hexaenoyl]oxy}propoxy]phosphonic acid

C27H41O9P (540.2488066)


PA(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/2:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/2:0), in particular, consists of one chain of one 7-hydroxy-docosahexaenoyl at the C-1 position and one chain of acetyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

   

PA(2:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14))

[(2R)-3-(acetyloxy)-2-{[(4Z,7Z,10Z,12E,16Z,19Z)-14-hydroxydocosa-4,7,10,12,16,19-hexaenoyl]oxy}propoxy]phosphonic acid

C27H41O9P (540.2488066)


PA(2:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(2:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)), in particular, consists of one chain of one acetyl at the C-1 position and one chain of 14-hydroxy-docosahexaenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

   

PA(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/2:0)

[(2R)-2-(Acetyloxy)-3-{[(4Z,7Z,10Z,16Z,19Z)-14-hydroxydocosa-4,7,10,12,16,19-hexaenoyl]oxy}propoxy]phosphonate

C27H41O9P (540.2488066)


PA(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/2:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/2:0), in particular, consists of one chain of one 14-hydroxy-docosahexaenoyl at the C-1 position and one chain of acetyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

   

PA(2:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17))

[(2R)-3-(acetyloxy)-2-{[(4Z,7Z,10Z,13E,15E,19Z)-17-hydroxydocosa-4,7,10,13,15,19-hexaenoyl]oxy}propoxy]phosphonic acid

C27H41O9P (540.2488066)


PA(2:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(2:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)), in particular, consists of one chain of one acetyl at the C-1 position and one chain of 17-hydroxy-docosahexaenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

   

PA(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/2:0)

[(2R)-2-(acetyloxy)-3-{[(4Z,7Z,10Z,13E,15E,19Z)-17-hydroxydocosa-4,7,10,13,15,19-hexaenoyl]oxy}propoxy]phosphonic acid

C27H41O9P (540.2488066)


PA(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/2:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/2:0), in particular, consists of one chain of one 17-hydroxy-docosahexaenoyl at the C-1 position and one chain of acetyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

   

PA(2:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17))

[(2R)-3-(acetyloxy)-2-{[(4Z,7Z,10Z,13Z)-15-{3-[(2Z)-pent-2-en-1-yl]oxiran-2-yl}pentadeca-4,7,10,13-tetraenoyl]oxy}propoxy]phosphonic acid

C27H41O9P (540.2488066)


PA(2:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(2:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)), in particular, consists of one chain of one acetyl at the C-1 position and one chain of 16,17-epoxy-docosapentaenoyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

   

PA(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/2:0)

[(2R)-2-(acetyloxy)-3-{[(4Z,7Z,10Z,13Z)-15-{3-[(2Z)-pent-2-en-1-yl]oxiran-2-yl}pentadeca-4,7,10,13-tetraenoyl]oxy}propoxy]phosphonic acid

C27H41O9P (540.2488066)


PA(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/2:0) is an oxidized phosphatidic acid (PA). Oxidized phosphatidic acids are glycerophospholipids in which a phosphate moiety occupies a glycerol substitution site and at least one of the fatty acyl chains has undergone oxidation. As all oxidized lipids, oxidized phosphatidic acids belong to a group of biomolecules that have a role as signaling molecules. The biosynthesis of oxidized lipids is mediated by several enzymatic families, including cyclooxygenases (COX), lipoxygenases (LOX) and cytochrome P450s (CYP). Non-enzymatically oxidized lipids are produced by uncontrolled oxidation through free radicals and are considered harmful to human health (PMID: 33329396). As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths, saturation and degrees of oxidation attached at the C-1 and C-2 positions. PA(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/2:0), in particular, consists of one chain of one 16,17-epoxy-docosapentaenoyl at the C-1 position and one chain of acetyl at the C-2 position. Phospholipids are ubiquitous in nature and are key components of the lipid bilayer of cells, as well as being involved in metabolism and signaling. Similarly to what occurs with phospholipids, the fatty acid distribution at the C-1 and C-2 positions of glycerol within oxidized phospholipids is continually in flux, owing to phospholipid degradation and the continuous phospholipid remodeling that occurs while these molecules are in membranes. Oxidized PAs can be synthesized via three different routes. In one route, the oxidized PA is synthetized de novo following the same mechanisms as for PAs but incorporating oxidized acyl chains (PMID: 33329396). An alternative is the transacylation of one of the non-oxidized acyl chains with an oxidized acylCoA (PMID: 33329396). The third pathway results from the oxidation of the acyl chain while still attached to the PA backbone, mainly through the action of LOX (PMID: 33329396).

   
   
   

Globostellatic acid A

Globostellatic acid A

C32H44O7 (540.3086874)


A tricyclic triterpenoid of the isomalabaricane group.

   
   
   
   
   

IVHD-valtrate

[6-Acetyloxy-4a-hydroxy-1-(3-methylbutanoyloxy)spiro[1,5,6,7a-tetrahydrocyclopenta[c]pyran-7,2-oxirane]-4-yl]methyl 3-methyl-2-(3-methylbutanoyloxy)butanoate

C27H40O11 (540.257049)


[6-Acetyloxy-4a-hydroxy-1-(3-methylbutanoyloxy)spiro[1,5,6,7a-tetrahydrocyclopenta[c]pyran-7,2-oxirane]-4-yl]methyl 3-methyl-2-(3-methylbutanoyloxy)butanoate is a natural product found in Valeriana officinalis and Valeriana jatamansi with data available.

   

Valtrate hydrine B3

Valtrate hydrine B3

C27H40O11 (540.257049)


   
   
   
   
   
   
   
   
   

5-Ketomilbemycin A4

5-Ketomilbemycin A4

C32H44O7 (540.3086874)


   

(1R*,2R*,3E,7R*,9R*,11R*,12S*)-16-O-(3-hydroxy-3-methylglutaryl)-18-O-acetyldolabella-3,8(17)-dien-2,7,9,16,18-pentol

(1R*,2R*,3E,7R*,9R*,11R*,12S*)-16-O-(3-hydroxy-3-methylglutaryl)-18-O-acetyldolabella-3,8(17)-dien-2,7,9,16,18-pentol

C28H44O10 (540.2934324)


   

11-Cinnamoyl,12-Ac- Condurangamine B|condurangogenin C

11-Cinnamoyl,12-Ac- Condurangamine B|condurangogenin C

C32H44O7 (540.3086874)


   

3beta,9alpha-diacetoxy-7beta-benzoyloxy-15beta-hydroxy-14-oxo-2betaH-jatropha-5E,12E-diene|pubescene D

3beta,9alpha-diacetoxy-7beta-benzoyloxy-15beta-hydroxy-14-oxo-2betaH-jatropha-5E,12E-diene|pubescene D

C31H40O8 (540.2723040000001)


   

3-O-(2E ,4E-Decadienoyl)-20-O-acetylingenol

[(4S,5S,6R,10R,12R,14R)-7-(acetyloxymethyl)-5,6-dihydroxy-3,11,11,14-tetramethyl-15-oxo-4-tetracyclo[7.5.1.01,5.010,12]pentadeca-2,7-dienyl] (2E,4E)-deca-2,4-dienoate

C32H44O7 (540.3086874)


   
   

9-Acetoxy-gamma-geraniol-1-O-(4,6-diacetyl-3-angelyl)-beta-D-glucopyranoside|9-Acetoxy-gamma-geraniol-1-O-<4,6-diacetyl-3-angelyl>-beta-D-glucopyranoside

9-Acetoxy-gamma-geraniol-1-O-(4,6-diacetyl-3-angelyl)-beta-D-glucopyranoside|9-Acetoxy-gamma-geraniol-1-O-<4,6-diacetyl-3-angelyl>-beta-D-glucopyranoside

C27H40O11 (540.257049)


   
   

16-ketopetuniasterone D 7-acetate

16-ketopetuniasterone D 7-acetate

C32H44O7 (540.3086874)


   

Resibufogenin 3-hydrogen suberate

Resibufogenin 3-hydrogen suberate

C32H44O7 (540.3086874)


   

6beta-acetoxy-8,13-epoxy-labd-14-en-11-one-1alpha-O-beta-glucopyranoside|forskoditerpenoside E

6beta-acetoxy-8,13-epoxy-labd-14-en-11-one-1alpha-O-beta-glucopyranoside|forskoditerpenoside E

C28H44O10 (540.2934324)


   
   

20-O-acetyl-[5-O-(2E,4Z)-decadienoyl]-ingenol|5-O-(2E,4Z-decadienoyl)-20-O-acetylingenol

20-O-acetyl-[5-O-(2E,4Z)-decadienoyl]-ingenol|5-O-(2E,4Z-decadienoyl)-20-O-acetylingenol

C32H44O7 (540.3086874)


   

6beta-O-(2,8-dimethyl-<2E,6E>-octadienoyl)-boschnaloside|6beta-O-(2,8-dimethyl-[2E,6E]-octadienoyl)-boschnaloside

6beta-O-(2,8-dimethyl-<2E,6E>-octadienoyl)-boschnaloside|6beta-O-(2,8-dimethyl-[2E,6E]-octadienoyl)-boschnaloside

C27H40O11 (540.257049)


   

(1R*,2R*,3E,7R*,8S*,9R*,11R*,12S*)-2-O-acetyl-16-O-(3-hydroxy-3-methylglutaryl)-8,9-epoxydolabell-3-en-2,7,16,18-tetrol

(1R*,2R*,3E,7R*,8S*,9R*,11R*,12S*)-2-O-acetyl-16-O-(3-hydroxy-3-methylglutaryl)-8,9-epoxydolabell-3-en-2,7,16,18-tetrol

C28H44O10 (540.2934324)


   
   
   
   

3-O-(2E,4Z-decadienoyl)-5-O-acetylingenol

3-O-(2E,4Z-decadienoyl)-5-O-acetylingenol

C32H44O7 (540.3086874)


   
   
   

(+)-(7S,8S,8R,8R)-4,4-dihydroxy-3,3,3,5-tetramethoxy-4,8-oxy-8,8-sesquineolignan-7-ol

(+)-(7S,8S,8R,8R)-4,4-dihydroxy-3,3,3,5-tetramethoxy-4,8-oxy-8,8-sesquineolignan-7-ol

C31H40O8 (540.2723040000001)


A neolignan isolated from the bark of Machilus robusta.

   

16-acetoxy-22alpha-hydroxy-29-nor-24-methyl-6,7-epoxycycloart-1,24(24a)-dien-3,23-dion-3,4-lactone|6,7-epoxyneomacrolactone

16-acetoxy-22alpha-hydroxy-29-nor-24-methyl-6,7-epoxycycloart-1,24(24a)-dien-3,23-dion-3,4-lactone|6,7-epoxyneomacrolactone

C32H44O7 (540.3086874)


   

(1S,4S,5S,6R,7R,8S,9S,10S)-15-acetoxy-1,9-dibenzoyloxy-4,6,8-trihydroxy-dihydro-beta-agarofuran

(1S,4S,5S,6R,7R,8S,9S,10S)-15-acetoxy-1,9-dibenzoyloxy-4,6,8-trihydroxy-dihydro-beta-agarofuran

C31H40O8 (540.2723040000001)


   

granatumin H|methyl rel-(4R,4aR,6aS,7R,8S,10R,11S,12bS)-4-(furan-3-yl)-1,4,4a,5,6,6a,7,8,9,10,11,12b-dodecahydro-4a,7,9,9-tetramethyl-10-(2-methyl-1-oxopropoxy)-2,13-dioxo-7,11-methano-2H-cycloocta[3,4]benzo[1,2-c]pyran-8-acetate

granatumin H|methyl rel-(4R,4aR,6aS,7R,8S,10R,11S,12bS)-4-(furan-3-yl)-1,4,4a,5,6,6a,7,8,9,10,11,12b-dodecahydro-4a,7,9,9-tetramethyl-10-(2-methyl-1-oxopropoxy)-2,13-dioxo-7,11-methano-2H-cycloocta[3,4]benzo[1,2-c]pyran-8-acetate

C31H40O8 (540.2723040000001)


   

methyl 3,7,11,12,15,23-hexaoxo-5alpha-lanost-8-en-26-oate

3,7,11,12,15,23-Hexaoxo-5alpha-lanosta-8-ene-26-oic acid methyl ester

C31H40O8 (540.2723040000001)


   

flickinflimioside A

flickinflimioside A

C28H44O10 (540.2934324)


   

ethyl 3,7,11,12,15,23-hexaoxo-5alpha-lanost-8-en-26-oate

ethyl 3,7,11,12,15,23-hexaoxo-5alpha-lanost-8-en-26-oate

C32H44O7 (540.3086874)


   
   

(1R*,2R*,3E,7R*,8S*,9R*,11R*,12S*)-16-O-(3-hydroxy-3-methylglutaryl)-18-O-acetyl-8,9-epoxydolabell-3-en-2,7,16,18-tetrol

(1R*,2R*,3E,7R*,8S*,9R*,11R*,12S*)-16-O-(3-hydroxy-3-methylglutaryl)-18-O-acetyl-8,9-epoxydolabell-3-en-2,7,16,18-tetrol

C28H44O10 (540.2934324)


   

6,7-secoeunicellin|klysimplexin P

6,7-secoeunicellin|klysimplexin P

C28H44O10 (540.2934324)


   

3-oxo-7,8-dihydro-alpha-ionyl tetra-O-acetyl-beta-D-glucopyranoside|blumenol C-O-beta-D-tetraacetylglucopyranoside

3-oxo-7,8-dihydro-alpha-ionyl tetra-O-acetyl-beta-D-glucopyranoside|blumenol C-O-beta-D-tetraacetylglucopyranoside

C27H40O11 (540.257049)


   

(20S,22S,23S,24S,25S,26S)-5alpha-chloro-12alpha,22-23,26,24,25-triepoxy-6beta,12beta,17beta,26-tetrahydroxyergosta-1-one|jaborosalactol 26

(20S,22S,23S,24S,25S,26S)-5alpha-chloro-12alpha,22-23,26,24,25-triepoxy-6beta,12beta,17beta,26-tetrahydroxyergosta-1-one|jaborosalactol 26

C28H41ClO8 (540.2489816000001)


   
   

(1R*,2R*,3E,7R*,9R*,11R*,12S*)-2-O-acetyl-16-O-(3-hydroxy-3-methylglutaryl)-dolabella-3,8(17)-dien-2,7,9,16,18-pentol

(1R*,2R*,3E,7R*,9R*,11R*,12S*)-2-O-acetyl-16-O-(3-hydroxy-3-methylglutaryl)-dolabella-3,8(17)-dien-2,7,9,16,18-pentol

C28H44O10 (540.2934324)


   
   

20-Deoxy,3,5-dibenzoyl-Ingenol|20-deoxyingenol-3,5-dibenzoate

20-Deoxy,3,5-dibenzoyl-Ingenol|20-deoxyingenol-3,5-dibenzoate

C34H36O6 (540.2511756)


   

1,3,7-tri-O-acetyl-14,15-deoxyhavanensin|14,15-deoxyhavanensin triacetate

1,3,7-tri-O-acetyl-14,15-deoxyhavanensin|14,15-deoxyhavanensin triacetate

C32H44O7 (540.3086874)


   
   

Isovaleroxy-hydroxy dihydrovaltrate

Isovaleroxy-hydroxy dihydrovaltrate

C27H40O11 (540.257049)


   

heteroclitalactone M

heteroclitalactone M

C32H44O7 (540.3086874)


   

2-acetyl cucurbitacin S

2-acetyl cucurbitacin S

C32H44O7 (540.3086874)


   

5,14-diacetoxy-3-benzoyloxy-15-hydroxy-9-oxojatropha-6(17),11E-diene|guyonianin E

5,14-diacetoxy-3-benzoyloxy-15-hydroxy-9-oxojatropha-6(17),11E-diene|guyonianin E

C31H40O8 (540.2723040000001)


   

6-oxo-drimenol-3alpha-isovalerate-isofraxidin-ether

6-oxo-drimenol-3alpha-isovalerate-isofraxidin-ether

C31H40O8 (540.2723040000001)


   

Thr Pro Pro Val Gln

Thr Pro Pro Val Gln

C24H40N6O8 (540.290748)


   

His Glu Gln Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-4-carboxybutanamido]-4-carbamoylbutanamido]hexanoic acid

C22H36N8O8 (540.2655976)


   
   

12b-O-[octa-2Z,4E-dienoyl]-13_-isobutyroyloxy-4b-deoxyphorbol

"12b-O-[octa-2Z,4E-dienoyl]-13_-isobutyroyloxy-4b-deoxyphorbol "

C32H44O7 (540.3086874)


   

C31H40O8_(1R,5R,6R,13R,14R,16S)-6-(3-Furyl)-16-(2-methoxy-2-oxoethyl)-1,5,15,15-tetramethyl-8,17-dioxo-7-oxatetracyclo[11.3.1.0~2,11~.0~5,10~]heptadec-10-en-14-yl 2-methylpropanoate

NCGC00385727-01_C31H40O8_(1R,5R,6R,13R,14R,16S)-6-(3-Furyl)-16-(2-methoxy-2-oxoethyl)-1,5,15,15-tetramethyl-8,17-dioxo-7-oxatetracyclo[11.3.1.0~2,11~.0~5,10~]heptadec-10-en-14-yl 2-methylpropanoate

C31H40O8 (540.2723040000001)


   

Ingenol O-Decadienoyl, O-Ac or isomer putative

Ingenol O-Decadienoyl, O-Ac or isomer putative

C32H44O7 (540.3086874)


   

12-O-[octa-2Z,4E-dienoyl]-13-isobutyroyloxy-4-deoxyphorbol

12-O-[octa-2Z,4E-dienoyl]-13-isobutyroyloxy-4-deoxyphorbol

C32H44O7 (540.3086874)


   

Ala His Lys Trp

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(1H-imidazol-4-yl)propanamido]hexanamido]-3-(1H-indol-3-yl)propanoic acid

C26H36N8O5 (540.2808526)


   

Ala His Gln Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(1H-imidazol-4-yl)propanamido]-4-carbamoylbutanamido]-3-(1H-indol-3-yl)propanoic acid

C25H32N8O6 (540.2444691999999)


   

Ala His Trp Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-(1H-indol-3-yl)propanamido]hexanoic acid

C26H36N8O5 (540.2808526)


   

Ala His Trp Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-(1H-indol-3-yl)propanamido]-4-carbamoylbutanoic acid

C25H32N8O6 (540.2444691999999)


   

Ala Lys His Trp

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-aminopropanamido]hexanamido]-3-(1H-imidazol-4-yl)propanamido]-3-(1H-indol-3-yl)propanoic acid

C26H36N8O5 (540.2808526)


   

Ala Lys Trp His

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-aminopropanamido]hexanamido]-3-(1H-indol-3-yl)propanamido]-3-(1H-imidazol-4-yl)propanoic acid

C26H36N8O5 (540.2808526)


   

Ala Gln His Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-carbamoylbutanamido]-3-(1H-imidazol-4-yl)propanamido]-3-(1H-indol-3-yl)propanoic acid

C25H32N8O6 (540.2444691999999)


   

Ala Gln Trp His

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-carbamoylbutanamido]-3-(1H-indol-3-yl)propanamido]-3-(1H-imidazol-4-yl)propanoic acid

C25H32N8O6 (540.2444691999999)


   

Ala Trp His Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(1H-indol-3-yl)propanamido]-3-(1H-imidazol-4-yl)propanamido]hexanoic acid

C26H36N8O5 (540.2808526)


   

Ala Trp His Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(1H-indol-3-yl)propanamido]-3-(1H-imidazol-4-yl)propanamido]-4-carbamoylbutanoic acid

C25H32N8O6 (540.2444691999999)


   

Ala Trp Lys His

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(1H-indol-3-yl)propanamido]hexanamido]-3-(1H-imidazol-4-yl)propanoic acid

C26H36N8O5 (540.2808526)


   

Ala Trp Gln His

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-(1H-indol-3-yl)propanamido]-4-carbamoylbutanamido]-3-(1H-imidazol-4-yl)propanoic acid

C25H32N8O6 (540.2444691999999)


   

Cys Lys Lys Tyr

(2S)-2-[(2S)-6-amino-2-[(2S)-6-amino-2-[(2R)-2-amino-3-sulfanylpropanamido]hexanamido]hexanamido]-3-(4-hydroxyphenyl)propanoic acid

C24H40N6O6S (540.27299)


   

Cys Lys Tyr Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-6-amino-2-[(2R)-2-amino-3-sulfanylpropanamido]hexanamido]-3-(4-hydroxyphenyl)propanamido]hexanoic acid

C24H40N6O6S (540.27299)


   

Cys Tyr Lys Lys

(2S)-6-amino-2-[(2S)-6-amino-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-(4-hydroxyphenyl)propanamido]hexanamido]hexanoic acid

C24H40N6O6S (540.27299)


   

Asp Phe Phe Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-phenylpropanamido]-3-phenylpropanamido]-3-methylpentanoic acid

C28H36N4O7 (540.2583866)


   

Asp Phe Phe Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-phenylpropanamido]-3-phenylpropanamido]-4-methylpentanoic acid

C28H36N4O7 (540.2583866)


   

Asp Phe Ile Phe

(3S)-3-amino-3-{[(1S)-1-{[(1S,2S)-1-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}-2-methylbutyl]carbamoyl}-2-phenylethyl]carbamoyl}propanoic acid

C28H36N4O7 (540.2583866)


   

Asp Phe Leu Phe

(3S)-3-amino-3-{[(1S)-1-{[(1S)-1-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}-3-methylbutyl]carbamoyl}-2-phenylethyl]carbamoyl}propanoic acid

C28H36N4O7 (540.2583866)


   

Asp His Asn Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-carbamoylpropanamido]-5-carbamimidamidopentanoic acid

C20H32N10O8 (540.2404472000001)


   

Asp His Arg Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-(1H-imidazol-4-yl)propanamido]-5-carbamimidamidopentanamido]-3-carbamoylpropanoic acid

C20H32N10O8 (540.2404472000001)


   

Asp Ile Phe Phe

(3S)-3-amino-3-{[(1S,2S)-1-{[(1S)-1-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}-2-phenylethyl]carbamoyl}-2-methylbutyl]carbamoyl}propanoic acid

C28H36N4O7 (540.2583866)


   

Asp Leu Phe Phe

(3S)-3-amino-3-{[(1S)-1-{[(1S)-1-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}-2-phenylethyl]carbamoyl}-3-methylbutyl]carbamoyl}propanoic acid

C28H36N4O7 (540.2583866)


   

Asp Asn His Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-3-carbamoylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-5-carbamimidamidopentanoic acid

C20H32N10O8 (540.2404472000001)


   

Asp Asn Arg His

(3S)-3-amino-3-{[(1S)-1-{[(1S)-4-carbamimidamido-1-{[(1S)-1-carboxy-2-(1H-imidazol-4-yl)ethyl]carbamoyl}butyl]carbamoyl}-2-carbamoylethyl]carbamoyl}propanoic acid

C20H32N10O8 (540.2404472000001)


   

Asp Arg His Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carboxypropanamido]-5-carbamimidamidopentanamido]-3-(1H-imidazol-4-yl)propanamido]-3-carbamoylpropanoic acid

C20H32N10O8 (540.2404472000001)


   

Asp Arg Asn His

(3S)-3-amino-3-{[(1S)-4-carbamimidamido-1-{[(1S)-2-carbamoyl-1-{[(1S)-1-carboxy-2-(1H-imidazol-4-yl)ethyl]carbamoyl}ethyl]carbamoyl}butyl]carbamoyl}propanoic acid

C20H32N10O8 (540.2404472000001)


   

Glu Phe Phe Val

(4S)-4-amino-4-{[(1S)-1-{[(1S)-1-{[(1S)-1-carboxy-2-methylpropyl]carbamoyl}-2-phenylethyl]carbamoyl}-2-phenylethyl]carbamoyl}butanoic acid

C28H36N4O7 (540.2583866)


   

Glu Phe Val Phe

(4S)-4-amino-4-{[(1S)-1-{[(1S)-1-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}-2-methylpropyl]carbamoyl}-2-phenylethyl]carbamoyl}butanoic acid

C28H36N4O7 (540.2583866)


   

Glu His Lys Lys

(2S)-6-amino-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-3-(1H-imidazol-4-yl)propanamido]hexanamido]hexanoic acid

C23H40N8O7 (540.3019810000001)


   

Glu His Lys Gln

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-3-(1H-imidazol-4-yl)propanamido]hexanamido]-4-carbamoylbutanoic acid

C22H36N8O8 (540.2655976)


   

Glu His Gln Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-3-(1H-imidazol-4-yl)propanamido]-4-carbamoylbutanamido]hexanoic acid

C22H36N8O8 (540.2655976)


   

Glu Lys His Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-4-carboxybutanamido]hexanamido]-3-(1H-imidazol-4-yl)propanamido]hexanoic acid

C23H40N8O7 (540.3019810000001)


   

Glu Lys His Gln

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-4-carboxybutanamido]hexanamido]-3-(1H-imidazol-4-yl)propanamido]-4-carbamoylbutanoic acid

C22H36N8O8 (540.2655976)


   

Glu Lys Lys His

(4S)-4-amino-4-{[(1S)-5-amino-1-{[(1S)-5-amino-1-{[(1S)-1-carboxy-2-(1H-imidazol-4-yl)ethyl]carbamoyl}pentyl]carbamoyl}pentyl]carbamoyl}butanoic acid

C23H40N8O7 (540.3019810000001)


   

Glu Lys Gln His

(4S)-4-amino-4-{[(1S)-5-amino-1-{[(1S)-3-carbamoyl-1-{[(1S)-1-carboxy-2-(1H-imidazol-4-yl)ethyl]carbamoyl}propyl]carbamoyl}pentyl]carbamoyl}butanoic acid

C22H36N8O8 (540.2655976)


   

Glu Gln His Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-4-carbamoylbutanamido]-3-(1H-imidazol-4-yl)propanamido]hexanoic acid

C22H36N8O8 (540.2655976)


   

Glu Gln Lys His

(4S)-4-amino-4-{[(1S)-1-{[(1S)-5-amino-1-{[(1S)-1-carboxy-2-(1H-imidazol-4-yl)ethyl]carbamoyl}pentyl]carbamoyl}-3-carbamoylpropyl]carbamoyl}butanoic acid

C22H36N8O8 (540.2655976)


   

Glu Val Phe Phe

(4S)-4-amino-4-{[(1S)-1-{[(1S)-1-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}-2-phenylethyl]carbamoyl}-2-methylpropyl]carbamoyl}butanoic acid

C28H36N4O7 (540.2583866)


   

Phe Asp Phe Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-carboxypropanamido]-3-phenylpropanamido]-3-methylpentanoic acid

C28H36N4O7 (540.2583866)


   

Phe Asp Phe Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-carboxypropanamido]-3-phenylpropanamido]-4-methylpentanoic acid

C28H36N4O7 (540.2583866)


   

Phe Asp Ile Phe

(3S)-3-[(2S)-2-amino-3-phenylpropanamido]-3-{[(1S,2S)-1-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}-2-methylbutyl]carbamoyl}propanoic acid

C28H36N4O7 (540.2583866)


   

Phe Asp Leu Phe

(3S)-3-[(2S)-2-amino-3-phenylpropanamido]-3-{[(1S)-1-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}-3-methylbutyl]carbamoyl}propanoic acid

C28H36N4O7 (540.2583866)


   

Phe Glu Phe Val

(4S)-4-[(2S)-2-amino-3-phenylpropanamido]-4-{[(1S)-1-{[(1S)-1-carboxy-2-methylpropyl]carbamoyl}-2-phenylethyl]carbamoyl}butanoic acid

C28H36N4O7 (540.2583866)


   

Phe Glu Val Phe

(4S)-4-[(2S)-2-amino-3-phenylpropanamido]-4-{[(1S)-1-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}-2-methylpropyl]carbamoyl}butanoic acid

C28H36N4O7 (540.2583866)


   

Phe Phe Asp Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-phenylpropanamido]-3-carboxypropanamido]-3-methylpentanoic acid

C28H36N4O7 (540.2583866)


   

Phe Phe Asp Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-phenylpropanamido]-3-carboxypropanamido]-4-methylpentanoic acid

C28H36N4O7 (540.2583866)


   

Phe Phe Glu Val

(4S)-4-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-phenylpropanamido]-4-{[(1S)-1-carboxy-2-methylpropyl]carbamoyl}butanoic acid

C28H36N4O7 (540.2583866)


   

Phe Phe Ile Asp

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-phenylpropanamido]-3-methylpentanamido]butanedioic acid

C28H36N4O7 (540.2583866)


   

Phe Phe Leu Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-phenylpropanamido]-4-methylpentanamido]butanedioic acid

C28H36N4O7 (540.2583866)


   

Phe Phe Met Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-phenylpropanamido]-4-(methylsulfanyl)butanoyl]pyrrolidine-2-carboxylic acid

C28H36N4O5S (540.2406286)


   

Phe Phe Pro Met

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-phenylpropanoyl]pyrrolidin-2-yl]formamido}-4-(methylsulfanyl)butanoic acid

C28H36N4O5S (540.2406286)


   

Phe Phe Val Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-phenylpropanamido]-3-methylbutanamido]pentanedioic acid

C28H36N4O7 (540.2583866)


   

Phe His His Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-(1H-imidazol-4-yl)propanamido]-3-hydroxybutanoic acid

C25H32N8O6 (540.2444691999999)


   

Phe His Thr His

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-hydroxybutanamido]-3-(1H-imidazol-4-yl)propanoic acid

C25H32N8O6 (540.2444691999999)


   

Phe Ile Asp Phe

(3S)-3-[(2S,3S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylpentanamido]-3-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}propanoic acid

C28H36N4O7 (540.2583866)


   

Phe Ile Phe Asp

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylpentanamido]-3-phenylpropanamido]butanedioic acid

C28H36N4O7 (540.2583866)


   

Phe Ile Met Met

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylpentanamido]-4-(methylsulfanyl)butanamido]-4-(methylsulfanyl)butanoic acid

C25H40N4O5S2 (540.243999)


   

Phe Ile Val Tyr

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylpentanamido]-3-methylbutanamido]-3-(4-hydroxyphenyl)propanoic acid

C29H40N4O6 (540.29477)


   

Phe Ile Tyr Val

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylpentanamido]-3-(4-hydroxyphenyl)propanamido]-3-methylbutanoic acid

C29H40N4O6 (540.29477)


   

Phe Leu Asp Phe

(3S)-3-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-methylpentanamido]-3-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}propanoic acid

C28H36N4O7 (540.2583866)


   

Phe Leu Phe Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-methylpentanamido]-3-phenylpropanamido]butanedioic acid

C28H36N4O7 (540.2583866)


   

Phe Leu Met Met

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-methylpentanamido]-4-(methylsulfanyl)butanamido]-4-(methylsulfanyl)butanoic acid

C25H40N4O5S2 (540.243999)


   

Phe Leu Val Tyr

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-methylpentanamido]-3-methylbutanamido]-3-(4-hydroxyphenyl)propanoic acid

C29H40N4O6 (540.29477)


   

Phe Leu Tyr Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-methylpentanamido]-3-(4-hydroxyphenyl)propanamido]-3-methylbutanoic acid

C29H40N4O6 (540.29477)


   

Phe Met Phe Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-(methylsulfanyl)butanamido]-3-phenylpropanoyl]pyrrolidine-2-carboxylic acid

C28H36N4O5S (540.2406286)


   

Phe Met Ile Met

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-(methylsulfanyl)butanamido]-3-methylpentanamido]-4-(methylsulfanyl)butanoic acid

C25H40N4O5S2 (540.243999)


   

Phe Met Leu Met

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-(methylsulfanyl)butanamido]-4-methylpentanamido]-4-(methylsulfanyl)butanoic acid

C25H40N4O5S2 (540.243999)


   

Phe Met Met Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-(methylsulfanyl)butanamido]-4-(methylsulfanyl)butanamido]-3-methylpentanoic acid

C25H40N4O5S2 (540.243999)


   

Phe Met Met Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-(methylsulfanyl)butanamido]-4-(methylsulfanyl)butanamido]-4-methylpentanoic acid

C25H40N4O5S2 (540.243999)


   

Phe Met Pro Phe

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-4-(methylsulfanyl)butanoyl]pyrrolidin-2-yl]formamido}-3-phenylpropanoic acid

C28H36N4O5S (540.2406286)


   

Phe Pro Phe Met

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-phenylpropanoyl]pyrrolidin-2-yl]formamido}-3-phenylpropanamido]-4-(methylsulfanyl)butanoic acid

C28H36N4O5S (540.2406286)


   

Phe Pro Met Phe

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-phenylpropanoyl]pyrrolidin-2-yl]formamido}-4-(methylsulfanyl)butanamido]-3-phenylpropanoic acid

C28H36N4O5S (540.2406286)


   

Phe Thr His His

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-3-phenylpropanamido]-3-hydroxybutanamido]-3-(1H-imidazol-4-yl)propanamido]-3-(1H-imidazol-4-yl)propanoic acid

C25H32N8O6 (540.2444691999999)


   

Phe Val Glu Phe

(4S)-4-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylbutanamido]-4-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}butanoic acid

C28H36N4O7 (540.2583866)


   

Phe Val Phe Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylbutanamido]-3-phenylpropanamido]pentanedioic acid

C28H36N4O7 (540.2583866)


   

Phe Val Ile Tyr

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylbutanamido]-3-methylpentanamido]-3-(4-hydroxyphenyl)propanoic acid

C29H40N4O6 (540.29477)


   

Phe Val Leu Tyr

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylbutanamido]-4-methylpentanamido]-3-(4-hydroxyphenyl)propanoic acid

C29H40N4O6 (540.29477)


   

Phe Val Tyr Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylbutanamido]-3-(4-hydroxyphenyl)propanamido]-3-methylpentanoic acid

C29H40N4O6 (540.29477)


   

Phe Val Tyr Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-methylbutanamido]-3-(4-hydroxyphenyl)propanamido]-4-methylpentanoic acid

C29H40N4O6 (540.29477)


   

Phe Tyr Ile Val

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-(4-hydroxyphenyl)propanamido]-3-methylpentanamido]-3-methylbutanoic acid

C29H40N4O6 (540.29477)


   

Phe Tyr Leu Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-(4-hydroxyphenyl)propanamido]-4-methylpentanamido]-3-methylbutanoic acid

C29H40N4O6 (540.29477)


   

Phe Tyr Val Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-(4-hydroxyphenyl)propanamido]-3-methylbutanamido]-3-methylpentanoic acid

C29H40N4O6 (540.29477)


   

Phe Tyr Val Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-phenylpropanamido]-3-(4-hydroxyphenyl)propanamido]-3-methylbutanamido]-4-methylpentanoic acid

C29H40N4O6 (540.29477)


   

His Ala Lys Trp

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]propanamido]hexanamido]-3-(1H-indol-3-yl)propanoic acid

C26H36N8O5 (540.2808526)


   

His Ala Gln Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]propanamido]-4-carbamoylbutanamido]-3-(1H-indol-3-yl)propanoic acid

C25H32N8O6 (540.2444691999999)


   

His Ala Trp Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]propanamido]-3-(1H-indol-3-yl)propanamido]hexanoic acid

C26H36N8O5 (540.2808526)


   

His Ala Trp Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]propanamido]-3-(1H-indol-3-yl)propanamido]-4-carbamoylbutanoic acid

C25H32N8O6 (540.2444691999999)


   

His Asp Asn Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-carboxypropanamido]-3-carbamoylpropanamido]-5-carbamimidamidopentanoic acid

C20H32N10O8 (540.2404472000001)


   

His Asp Arg Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-carboxypropanamido]-5-carbamimidamidopentanamido]-3-carbamoylpropanoic acid

C20H32N10O8 (540.2404472000001)


   

His Glu Lys Lys

(2S)-6-amino-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-4-carboxybutanamido]hexanamido]hexanoic acid

C23H40N8O7 (540.3019810000001)


   

His Glu Lys Gln

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-4-carboxybutanamido]hexanamido]-4-carbamoylbutanoic acid

C22H36N8O8 (540.2655976)


   

His Phe His Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-phenylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-hydroxybutanoic acid

C25H32N8O6 (540.2444691999999)


   

His Phe Thr His

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-phenylpropanamido]-3-hydroxybutanamido]-3-(1H-imidazol-4-yl)propanoic acid

C25H32N8O6 (540.2444691999999)


   

His His Phe Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-(1H-imidazol-4-yl)propanamido]-3-phenylpropanamido]-3-hydroxybutanoic acid

C25H32N8O6 (540.2444691999999)


   

His His Thr Phe

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-(1H-imidazol-4-yl)propanamido]-3-hydroxybutanamido]-3-phenylpropanoic acid

C25H32N8O6 (540.2444691999999)


   

His Lys Ala Trp

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]hexanamido]propanamido]-3-(1H-indol-3-yl)propanoic acid

C26H36N8O5 (540.2808526)


   

His Lys Glu Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]hexanamido]-4-carboxybutanamido]hexanoic acid

C23H40N8O7 (540.3019810000001)


   

His Lys Glu Gln

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]hexanamido]-4-carboxybutanamido]-4-carbamoylbutanoic acid

C22H36N8O8 (540.2655976)


   

His Lys Lys Glu

(2S)-2-[(2S)-6-amino-2-[(2S)-6-amino-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]hexanamido]hexanamido]pentanedioic acid

C23H40N8O7 (540.3019810000001)


   

His Lys Gln Glu

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]hexanamido]-4-carbamoylbutanamido]pentanedioic acid

C22H36N8O8 (540.2655976)


   

His Lys Trp Ala

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]hexanamido]-3-(1H-indol-3-yl)propanamido]propanoic acid

C26H36N8O5 (540.2808526)


   

His Asn Asp Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-carbamoylpropanamido]-3-carboxypropanamido]-5-carbamimidamidopentanoic acid

C20H32N10O8 (540.2404472000001)


   

His Asn Arg Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-carbamoylpropanamido]-5-carbamimidamidopentanamido]butanedioic acid

C20H32N10O8 (540.2404472000001)


   

His Gln Ala Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-4-carbamoylbutanamido]propanamido]-3-(1H-indol-3-yl)propanoic acid

C25H32N8O6 (540.2444691999999)


   

His Gln Glu Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-4-carbamoylbutanamido]-4-carboxybutanamido]hexanoic acid

C22H36N8O8 (540.2655976)


   

His Gln Lys Glu

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-4-carbamoylbutanamido]hexanamido]pentanedioic acid

C22H36N8O8 (540.2655976)


   

His Gln Arg Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-4-carbamoylbutanamido]-5-carbamimidamidopentanamido]-3-hydroxybutanoic acid

C21H36N10O7 (540.2768306)


   

His Gln Thr Arg

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-4-carbamoylbutanamido]-3-hydroxybutanamido]-5-carbamimidamidopentanoic acid

C21H36N10O7 (540.2768306)


   

His Gln Trp Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-4-carbamoylbutanamido]-3-(1H-indol-3-yl)propanamido]propanoic acid

C25H32N8O6 (540.2444691999999)


   

His Arg Asp Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-5-carbamimidamidopentanamido]-3-carboxypropanamido]-3-carbamoylpropanoic acid

C20H32N10O8 (540.2404472000001)


   

His Arg Asn Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-5-carbamimidamidopentanamido]-3-carbamoylpropanamido]butanedioic acid

C20H32N10O8 (540.2404472000001)


   

His Arg Gln Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-5-carbamimidamidopentanamido]-4-carbamoylbutanamido]-3-hydroxybutanoic acid

C21H36N10O7 (540.2768306)


   

His Arg Thr Gln

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-5-carbamimidamidopentanamido]-3-hydroxybutanamido]-4-carbamoylbutanoic acid

C21H36N10O7 (540.2768306)


   

His Thr Phe His

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-hydroxybutanamido]-3-phenylpropanamido]-3-(1H-imidazol-4-yl)propanoic acid

C25H32N8O6 (540.2444691999999)


   

His Thr His Phe

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-hydroxybutanamido]-3-(1H-imidazol-4-yl)propanamido]-3-phenylpropanoic acid

C25H32N8O6 (540.2444691999999)


   

His Thr Gln Arg

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-hydroxybutanamido]-4-carbamoylbutanamido]-5-carbamimidamidopentanoic acid

C21H36N10O7 (540.2768306)


   

His Thr Arg Gln

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-hydroxybutanamido]-5-carbamimidamidopentanamido]-4-carbamoylbutanoic acid

C21H36N10O7 (540.2768306)


   

His Trp Ala Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-(1H-indol-3-yl)propanamido]propanamido]hexanoic acid

C26H36N8O5 (540.2808526)


   

His Trp Ala Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-(1H-indol-3-yl)propanamido]propanamido]-4-carbamoylbutanoic acid

C25H32N8O6 (540.2444691999999)


   

His Trp Lys Ala

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-(1H-indol-3-yl)propanamido]hexanamido]propanoic acid

C26H36N8O5 (540.2808526)


   

His Trp Gln Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-(1H-indol-3-yl)propanamido]-4-carbamoylbutanamido]propanoic acid

C25H32N8O6 (540.2444691999999)


   

Ile Asp Phe Phe

(3S)-3-[(2S,3S)-2-amino-3-methylpentanamido]-3-{[(1S)-1-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}-2-phenylethyl]carbamoyl}propanoic acid

C28H36N4O7 (540.2583866)


   

Ile Phe Asp Phe

(3S)-3-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-phenylpropanamido]-3-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}propanoic acid

C28H36N4O7 (540.2583866)


   

Ile Phe Phe Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-phenylpropanamido]-3-phenylpropanamido]butanedioic acid

C28H36N4O7 (540.2583866)


   

Ile Phe Met Met

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-phenylpropanamido]-4-(methylsulfanyl)butanamido]-4-(methylsulfanyl)butanoic acid

C25H40N4O5S2 (540.243999)


   

Ile Phe Val Tyr

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-phenylpropanamido]-3-methylbutanamido]-3-(4-hydroxyphenyl)propanoic acid

C29H40N4O6 (540.29477)


   

Ile Phe Tyr Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-phenylpropanamido]-3-(4-hydroxyphenyl)propanamido]-3-methylbutanoic acid

C29H40N4O6 (540.29477)


   

Ile Met Phe Met

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-4-(methylsulfanyl)butanamido]-3-phenylpropanamido]-4-(methylsulfanyl)butanoic acid

C25H40N4O5S2 (540.243999)


   

Ile Met Met Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-4-(methylsulfanyl)butanamido]-4-(methylsulfanyl)butanamido]-3-phenylpropanoic acid

C25H40N4O5S2 (540.243999)


   

Ile Val Phe Tyr

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylbutanamido]-3-phenylpropanamido]-3-(4-hydroxyphenyl)propanoic acid

C29H40N4O6 (540.29477)


   

Ile Val Tyr Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-methylbutanamido]-3-(4-hydroxyphenyl)propanamido]-3-phenylpropanoic acid

C29H40N4O6 (540.29477)


   

Ile Tyr Phe Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-(4-hydroxyphenyl)propanamido]-3-phenylpropanamido]-3-methylbutanoic acid

C29H40N4O6 (540.29477)


   

Ile Tyr Val Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]-3-(4-hydroxyphenyl)propanamido]-3-methylbutanamido]-3-phenylpropanoic acid

C29H40N4O6 (540.29477)


   

Lys Ala His Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]propanamido]-3-(1H-imidazol-4-yl)propanamido]-3-(1H-indol-3-yl)propanoic acid

C26H36N8O5 (540.2808526)


   

Lys Ala Trp His

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]propanamido]-3-(1H-indol-3-yl)propanamido]-3-(1H-imidazol-4-yl)propanoic acid

C26H36N8O5 (540.2808526)


   

Lys Cys Lys Tyr

(2S)-2-[(2S)-6-amino-2-[(2R)-2-[(2S)-2,6-diaminohexanamido]-3-sulfanylpropanamido]hexanamido]-3-(4-hydroxyphenyl)propanoic acid

C24H40N6O6S (540.27299)


   

Lys Cys Tyr Lys

(2S)-6-amino-2-[(2S)-2-[(2R)-2-[(2S)-2,6-diaminohexanamido]-3-sulfanylpropanamido]-3-(4-hydroxyphenyl)propanamido]hexanoic acid

C24H40N6O6S (540.27299)


   

Lys Glu His Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-4-carboxy-2-[(2S)-2,6-diaminohexanamido]butanamido]-3-(1H-imidazol-4-yl)propanamido]hexanoic acid

C23H40N8O7 (540.3019810000001)


   

Lys Glu His Gln

(4S)-4-{[(1S)-1-{[(1S)-3-carbamoyl-1-carboxypropyl]carbamoyl}-2-(1H-imidazol-4-yl)ethyl]carbamoyl}-4-[(2S)-2,6-diaminohexanamido]butanoic acid

C22H36N8O8 (540.2655976)


   

Lys Glu Lys His

(4S)-4-{[(1S)-5-amino-1-{[(1S)-1-carboxy-2-(1H-imidazol-4-yl)ethyl]carbamoyl}pentyl]carbamoyl}-4-[(2S)-2,6-diaminohexanamido]butanoic acid

C23H40N8O7 (540.3019810000001)


   

Lys Glu Gln His

(4S)-4-{[(1S)-3-carbamoyl-1-{[(1S)-1-carboxy-2-(1H-imidazol-4-yl)ethyl]carbamoyl}propyl]carbamoyl}-4-[(2S)-2,6-diaminohexanamido]butanoic acid

C22H36N8O8 (540.2655976)


   

Lys His Ala Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-(1H-imidazol-4-yl)propanamido]propanamido]-3-(1H-indol-3-yl)propanoic acid

C26H36N8O5 (540.2808526)


   

Lys His Glu Lys

(2S)-6-amino-2-[(2S)-4-carboxy-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-(1H-imidazol-4-yl)propanamido]butanamido]hexanoic acid

C23H40N8O7 (540.3019810000001)


   

Lys His Glu Gln

(4S)-4-{[(1S)-3-carbamoyl-1-carboxypropyl]carbamoyl}-4-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-(1H-imidazol-4-yl)propanamido]butanoic acid

C22H36N8O8 (540.2655976)


   

Lys His Lys Glu

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-(1H-imidazol-4-yl)propanamido]hexanamido]pentanedioic acid

C23H40N8O7 (540.3019810000001)


   

Lys His Gln Glu

(2S)-2-[(2S)-4-carbamoyl-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-(1H-imidazol-4-yl)propanamido]butanamido]pentanedioic acid

C22H36N8O8 (540.2655976)


   

Lys His Trp Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-(1H-imidazol-4-yl)propanamido]-3-(1H-indol-3-yl)propanamido]propanoic acid

C26H36N8O5 (540.2808526)


   

Lys Lys Cys Tyr

(2S)-2-[(2R)-2-[(2S)-6-amino-2-[(2S)-2,6-diaminohexanamido]hexanamido]-3-sulfanylpropanamido]-3-(4-hydroxyphenyl)propanoic acid

C24H40N6O6S (540.27299)


   

Lys Lys Glu His

(4S)-4-[(2S)-6-amino-2-[(2S)-2,6-diaminohexanamido]hexanamido]-4-{[(1S)-1-carboxy-2-(1H-imidazol-4-yl)ethyl]carbamoyl}butanoic acid

C23H40N8O7 (540.3019810000001)


   

Lys Lys His Glu

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2,6-diaminohexanamido]hexanamido]-3-(1H-imidazol-4-yl)propanamido]pentanedioic acid

C23H40N8O7 (540.3019810000001)


   

Lys Lys Tyr Cys

(2R)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2,6-diaminohexanamido]hexanamido]-3-(4-hydroxyphenyl)propanamido]-3-sulfanylpropanoic acid

C24H40N6O6S (540.27299)


   

Lys Gln Glu His

(4S)-4-[(2S)-4-carbamoyl-2-[(2S)-2,6-diaminohexanamido]butanamido]-4-{[(1S)-1-carboxy-2-(1H-imidazol-4-yl)ethyl]carbamoyl}butanoic acid

C22H36N8O8 (540.2655976)


   

Lys Gln His Glu

(2S)-2-[(2S)-2-[(2S)-4-carbamoyl-2-[(2S)-2,6-diaminohexanamido]butanamido]-3-(1H-imidazol-4-yl)propanamido]pentanedioic acid

C22H36N8O8 (540.2655976)


   

Lys Trp Ala His

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-(1H-indol-3-yl)propanamido]propanamido]-3-(1H-imidazol-4-yl)propanoic acid

C26H36N8O5 (540.2808526)


   

Lys Trp His Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-(1H-indol-3-yl)propanamido]-3-(1H-imidazol-4-yl)propanamido]propanoic acid

C26H36N8O5 (540.2808526)


   

Lys Tyr Cys Lys

(2S)-6-amino-2-[(2R)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-(4-hydroxyphenyl)propanamido]-3-sulfanylpropanamido]hexanoic acid

C24H40N6O6S (540.27299)


   

Lys Tyr Lys Cys

(2R)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-(4-hydroxyphenyl)propanamido]hexanamido]-3-sulfanylpropanoic acid

C24H40N6O6S (540.27299)


   

Leu Asp Phe Phe

(3S)-3-[(2S)-2-amino-4-methylpentanamido]-3-{[(1S)-1-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}-2-phenylethyl]carbamoyl}propanoic acid

C28H36N4O7 (540.2583866)


   

Leu Phe Asp Phe

(3S)-3-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-phenylpropanamido]-3-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}propanoic acid

C28H36N4O7 (540.2583866)


   

Leu Phe Phe Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-phenylpropanamido]-3-phenylpropanamido]butanedioic acid

C28H36N4O7 (540.2583866)


   

Leu Phe Met Met

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-phenylpropanamido]-4-(methylsulfanyl)butanamido]-4-(methylsulfanyl)butanoic acid

C25H40N4O5S2 (540.243999)


   

Leu Phe Val Tyr

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-phenylpropanamido]-3-methylbutanamido]-3-(4-hydroxyphenyl)propanoic acid

C29H40N4O6 (540.29477)


   

Leu Phe Tyr Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-phenylpropanamido]-3-(4-hydroxyphenyl)propanamido]-3-methylbutanoic acid

C29H40N4O6 (540.29477)


   

Leu Met Phe Met

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-4-(methylsulfanyl)butanamido]-3-phenylpropanamido]-4-(methylsulfanyl)butanoic acid

C25H40N4O5S2 (540.243999)


   

Leu Met Met Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-4-(methylsulfanyl)butanamido]-4-(methylsulfanyl)butanamido]-3-phenylpropanoic acid

C25H40N4O5S2 (540.243999)


   

Leu Val Phe Tyr

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylbutanamido]-3-phenylpropanamido]-3-(4-hydroxyphenyl)propanoic acid

C29H40N4O6 (540.29477)


   

Leu Val Tyr Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-methylbutanamido]-3-(4-hydroxyphenyl)propanamido]-3-phenylpropanoic acid

C29H40N4O6 (540.29477)


   

Leu Tyr Phe Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-(4-hydroxyphenyl)propanamido]-3-phenylpropanamido]-3-methylbutanoic acid

C29H40N4O6 (540.29477)


   

Leu Tyr Val Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]-3-(4-hydroxyphenyl)propanamido]-3-methylbutanamido]-3-phenylpropanoic acid

C29H40N4O6 (540.29477)


   

Met Phe Phe Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-phenylpropanamido]-3-phenylpropanoyl]pyrrolidine-2-carboxylic acid

C28H36N4O5S (540.2406286)


   

Met Phe Ile Met

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-phenylpropanamido]-3-methylpentanamido]-4-(methylsulfanyl)butanoic acid

C25H40N4O5S2 (540.243999)


   

Met Phe Leu Met

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-phenylpropanamido]-4-methylpentanamido]-4-(methylsulfanyl)butanoic acid

C25H40N4O5S2 (540.243999)


   

Met Phe Met Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-phenylpropanamido]-4-(methylsulfanyl)butanamido]-3-methylpentanoic acid

C25H40N4O5S2 (540.243999)


   

Met Phe Met Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-phenylpropanamido]-4-(methylsulfanyl)butanamido]-4-methylpentanoic acid

C25H40N4O5S2 (540.243999)


   

Met Phe Pro Phe

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-phenylpropanoyl]pyrrolidin-2-yl]formamido}-3-phenylpropanoic acid

C28H36N4O5S (540.2406286)


   

Met Ile Phe Met

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-methylpentanamido]-3-phenylpropanamido]-4-(methylsulfanyl)butanoic acid

C25H40N4O5S2 (540.243999)


   

Met Ile Met Phe

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-3-methylpentanamido]-4-(methylsulfanyl)butanamido]-3-phenylpropanoic acid

C25H40N4O5S2 (540.243999)


   

Met Leu Phe Met

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-4-methylpentanamido]-3-phenylpropanamido]-4-(methylsulfanyl)butanoic acid

C25H40N4O5S2 (540.243999)


   

Met Leu Met Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-4-methylpentanamido]-4-(methylsulfanyl)butanamido]-3-phenylpropanoic acid

C25H40N4O5S2 (540.243999)


   

Met Met Phe Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-4-(methylsulfanyl)butanamido]-3-phenylpropanamido]-3-methylpentanoic acid

C25H40N4O5S2 (540.243999)


   

Met Met Phe Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-4-(methylsulfanyl)butanamido]-3-phenylpropanamido]-4-methylpentanoic acid

C25H40N4O5S2 (540.243999)


   

Met Met Ile Phe

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-4-(methylsulfanyl)butanamido]-3-methylpentanamido]-3-phenylpropanoic acid

C25H40N4O5S2 (540.243999)


   

Met Met Leu Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-(methylsulfanyl)butanamido]-4-(methylsulfanyl)butanamido]-4-methylpentanamido]-3-phenylpropanoic acid

C25H40N4O5S2 (540.243999)


   

Met Pro Phe Phe

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-4-(methylsulfanyl)butanoyl]pyrrolidin-2-yl]formamido}-3-phenylpropanamido]-3-phenylpropanoic acid

C28H36N4O5S (540.2406286)


   

Asn Asp His Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-carboxypropanamido]-3-(1H-imidazol-4-yl)propanamido]-5-carbamimidamidopentanoic acid

C20H32N10O8 (540.2404472000001)


   

Asn Asp Arg His

(3S)-3-[(2S)-2-amino-3-carbamoylpropanamido]-3-{[(1S)-4-carbamimidamido-1-{[(1S)-1-carboxy-2-(1H-imidazol-4-yl)ethyl]carbamoyl}butyl]carbamoyl}propanoic acid

C20H32N10O8 (540.2404472000001)


   

Asn His Asp Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-carboxypropanamido]-5-carbamimidamidopentanoic acid

C20H32N10O8 (540.2404472000001)


   

Asn His Arg Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-5-carbamimidamidopentanamido]butanedioic acid

C20H32N10O8 (540.2404472000001)


   

Asn Arg Asp His

(3S)-3-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-5-carbamimidamidopentanamido]-3-{[(1S)-1-carboxy-2-(1H-imidazol-4-yl)ethyl]carbamoyl}propanoic acid

C20H32N10O8 (540.2404472000001)


   

Asn Arg His Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-5-carbamimidamidopentanamido]-3-(1H-imidazol-4-yl)propanamido]butanedioic acid

C20H32N10O8 (540.2404472000001)


   

Pro Phe Phe Met

(2S)-4-(methylsulfanyl)-2-[(2S)-3-phenyl-2-[(2S)-3-phenyl-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]propanamido]butanoic acid

C28H36N4O5S (540.2406286)


   

Pro Phe Met Phe

(2S)-2-[(2S)-4-(methylsulfanyl)-2-[(2S)-3-phenyl-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]butanamido]-3-phenylpropanoic acid

C28H36N4O5S (540.2406286)


   

Pro Met Phe Phe

(2S)-2-[(2S)-2-[(2S)-4-(methylsulfanyl)-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]-3-phenylpropanamido]-3-phenylpropanoic acid

C28H36N4O5S (540.2406286)


   

Pro Val Tyr Tyr

(2S)-3-(4-hydroxyphenyl)-2-[(2S)-3-(4-hydroxyphenyl)-2-[(2S)-3-methyl-2-[(2S)-pyrrolidin-2-ylformamido]butanamido]propanamido]propanoic acid

C28H36N4O7 (540.2583866)


   

Pro Tyr Val Tyr

(2S)-3-(4-hydroxyphenyl)-2-[(2S)-2-[(2S)-3-(4-hydroxyphenyl)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-3-methylbutanamido]propanoic acid

C28H36N4O7 (540.2583866)


   

Pro Tyr Tyr Val

(2S)-2-[(2S)-3-(4-hydroxyphenyl)-2-[(2S)-3-(4-hydroxyphenyl)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]propanamido]-3-methylbutanoic acid

C28H36N4O7 (540.2583866)


   

Gln Ala His Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]propanamido]-3-(1H-imidazol-4-yl)propanamido]-3-(1H-indol-3-yl)propanoic acid

C25H32N8O6 (540.2444691999999)


   

Gln Ala Trp His

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]propanamido]-3-(1H-indol-3-yl)propanamido]-3-(1H-imidazol-4-yl)propanoic acid

C25H32N8O6 (540.2444691999999)


   

Gln Glu His Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-4-carboxybutanamido]-3-(1H-imidazol-4-yl)propanamido]hexanoic acid

C22H36N8O8 (540.2655976)


   

Gln Glu Lys His

(4S)-4-{[(1S)-5-amino-1-{[(1S)-1-carboxy-2-(1H-imidazol-4-yl)ethyl]carbamoyl}pentyl]carbamoyl}-4-[(2S)-2-amino-4-carbamoylbutanamido]butanoic acid

C22H36N8O8 (540.2655976)


   

Gln His Ala Trp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-(1H-imidazol-4-yl)propanamido]propanamido]-3-(1H-indol-3-yl)propanoic acid

C25H32N8O6 (540.2444691999999)


   

Gln His Glu Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-(1H-imidazol-4-yl)propanamido]-4-carboxybutanamido]hexanoic acid

C22H36N8O8 (540.2655976)


   

Gln His Lys Glu

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-(1H-imidazol-4-yl)propanamido]hexanamido]pentanedioic acid

C22H36N8O8 (540.2655976)


   

Gln His Arg Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-(1H-imidazol-4-yl)propanamido]-5-carbamimidamidopentanamido]-3-hydroxybutanoic acid

C21H36N10O7 (540.2768306)


   

Gln His Thr Arg

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-(1H-imidazol-4-yl)propanamido]-3-hydroxybutanamido]-5-carbamimidamidopentanoic acid

C21H36N10O7 (540.2768306)


   

Gln His Trp Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-(1H-imidazol-4-yl)propanamido]-3-(1H-indol-3-yl)propanamido]propanoic acid

C25H32N8O6 (540.2444691999999)


   

Gln Lys Glu His

(4S)-4-[(2S)-6-amino-2-[(2S)-2-amino-4-carbamoylbutanamido]hexanamido]-4-{[(1S)-1-carboxy-2-(1H-imidazol-4-yl)ethyl]carbamoyl}butanoic acid

C22H36N8O8 (540.2655976)


   

Gln Lys His Glu

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-4-carbamoylbutanamido]hexanamido]-3-(1H-imidazol-4-yl)propanamido]pentanedioic acid

C22H36N8O8 (540.2655976)


   

Gln Arg His Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-5-carbamimidamidopentanamido]-3-(1H-imidazol-4-yl)propanamido]-3-hydroxybutanoic acid

C21H36N10O7 (540.2768306)


   

Gln Arg Thr His

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-5-carbamimidamidopentanamido]-3-hydroxybutanamido]-3-(1H-imidazol-4-yl)propanoic acid

C21H36N10O7 (540.2768306)


   

Gln Thr His Arg

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-hydroxybutanamido]-3-(1H-imidazol-4-yl)propanamido]-5-carbamimidamidopentanoic acid

C21H36N10O7 (540.2768306)


   

Gln Thr Arg His

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-hydroxybutanamido]-5-carbamimidamidopentanamido]-3-(1H-imidazol-4-yl)propanoic acid

C21H36N10O7 (540.2768306)


   

Gln Trp Ala His

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-(1H-indol-3-yl)propanamido]propanamido]-3-(1H-imidazol-4-yl)propanoic acid

C25H32N8O6 (540.2444691999999)


   

Gln Trp His Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carbamoylbutanamido]-3-(1H-indol-3-yl)propanamido]-3-(1H-imidazol-4-yl)propanamido]propanoic acid

C25H32N8O6 (540.2444691999999)


   

Arg Asp His Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-carboxypropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-carbamoylpropanoic acid

C20H32N10O8 (540.2404472000001)


   

Arg Asp Asn His

(3S)-3-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-{[(1S)-2-carbamoyl-1-{[(1S)-1-carboxy-2-(1H-imidazol-4-yl)ethyl]carbamoyl}ethyl]carbamoyl}propanoic acid

C20H32N10O8 (540.2404472000001)


   

Arg His Asp Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-(1H-imidazol-4-yl)propanamido]-3-carboxypropanamido]-3-carbamoylpropanoic acid

C20H32N10O8 (540.2404472000001)


   

Arg His Asn Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-(1H-imidazol-4-yl)propanamido]-3-carbamoylpropanamido]butanedioic acid

C20H32N10O8 (540.2404472000001)


   

Arg His Gln Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-(1H-imidazol-4-yl)propanamido]-4-carbamoylbutanamido]-3-hydroxybutanoic acid

C21H36N10O7 (540.2768306)


   

Arg His Thr Gln

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-(1H-imidazol-4-yl)propanamido]-3-hydroxybutanamido]-4-carbamoylbutanoic acid

C21H36N10O7 (540.2768306)


   

Arg Gln His Thr

(2S,3R)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-4-carbamoylbutanamido]-3-(1H-imidazol-4-yl)propanamido]-3-hydroxybutanoic acid

C21H36N10O7 (540.2768306)


   

Arg Gln Thr His

(2S)-2-[(2S,3R)-2-[(2S)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-4-carbamoylbutanamido]-3-hydroxybutanamido]-3-(1H-imidazol-4-yl)propanoic acid

C21H36N10O7 (540.2768306)


   

Arg Thr His Gln

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-hydroxybutanamido]-3-(1H-imidazol-4-yl)propanamido]-4-carbamoylbutanoic acid

C21H36N10O7 (540.2768306)


   

Arg Thr Gln His

(2S)-2-[(2S)-2-[(2S,3R)-2-[(2S)-2-amino-5-carbamimidamidopentanamido]-3-hydroxybutanamido]-4-carbamoylbutanamido]-3-(1H-imidazol-4-yl)propanoic acid

C21H36N10O7 (540.2768306)


   

Thr Phe His His

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-phenylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-(1H-imidazol-4-yl)propanoic acid

C25H32N8O6 (540.2444691999999)


   

Thr His Phe His

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-(1H-imidazol-4-yl)propanamido]-3-phenylpropanamido]-3-(1H-imidazol-4-yl)propanoic acid

C25H32N8O6 (540.2444691999999)


   

Thr His His Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-(1H-imidazol-4-yl)propanamido]-3-(1H-imidazol-4-yl)propanamido]-3-phenylpropanoic acid

C25H32N8O6 (540.2444691999999)


   

Thr His Gln Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-(1H-imidazol-4-yl)propanamido]-4-carbamoylbutanamido]-5-carbamimidamidopentanoic acid

C21H36N10O7 (540.2768306)


   

Thr His Arg Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-3-(1H-imidazol-4-yl)propanamido]-5-carbamimidamidopentanamido]-4-carbamoylbutanoic acid

C21H36N10O7 (540.2768306)


   

Thr Gln His Arg

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-4-carbamoylbutanamido]-3-(1H-imidazol-4-yl)propanamido]-5-carbamimidamidopentanoic acid

C21H36N10O7 (540.2768306)


   

Thr Gln Arg His

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-4-carbamoylbutanamido]-5-carbamimidamidopentanamido]-3-(1H-imidazol-4-yl)propanoic acid

C21H36N10O7 (540.2768306)


   

Thr Arg His Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-5-carbamimidamidopentanamido]-3-(1H-imidazol-4-yl)propanamido]-4-carbamoylbutanoic acid

C21H36N10O7 (540.2768306)


   

Thr Arg Gln His

(2S)-2-[(2S)-2-[(2S)-2-[(2S,3R)-2-amino-3-hydroxybutanamido]-5-carbamimidamidopentanamido]-4-carbamoylbutanamido]-3-(1H-imidazol-4-yl)propanoic acid

C21H36N10O7 (540.2768306)


   

Val Glu Phe Phe

(4S)-4-[(2S)-2-amino-3-methylbutanamido]-4-{[(1S)-1-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}-2-phenylethyl]carbamoyl}butanoic acid

C28H36N4O7 (540.2583866)


   

Val Phe Glu Phe

(4S)-4-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-phenylpropanamido]-4-{[(1S)-1-carboxy-2-phenylethyl]carbamoyl}butanoic acid

C28H36N4O7 (540.2583866)


   

Val Phe Phe Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-phenylpropanamido]-3-phenylpropanamido]pentanedioic acid

C28H36N4O7 (540.2583866)


   

Val Phe Ile Tyr

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-phenylpropanamido]-3-methylpentanamido]-3-(4-hydroxyphenyl)propanoic acid

C29H40N4O6 (540.29477)


   

Val Phe Leu Tyr

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-phenylpropanamido]-4-methylpentanamido]-3-(4-hydroxyphenyl)propanoic acid

C29H40N4O6 (540.29477)


   

Val Phe Tyr Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-phenylpropanamido]-3-(4-hydroxyphenyl)propanamido]-3-methylpentanoic acid

C29H40N4O6 (540.29477)


   

Val Phe Tyr Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-phenylpropanamido]-3-(4-hydroxyphenyl)propanamido]-4-methylpentanoic acid

C29H40N4O6 (540.29477)


   

Val Ile Phe Tyr

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylpentanamido]-3-phenylpropanamido]-3-(4-hydroxyphenyl)propanoic acid

C29H40N4O6 (540.29477)


   

Val Ile Tyr Phe

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-methylbutanamido]-3-methylpentanamido]-3-(4-hydroxyphenyl)propanamido]-3-phenylpropanoic acid

C29H40N4O6 (540.29477)


   

Val Leu Phe Tyr

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-4-methylpentanamido]-3-phenylpropanamido]-3-(4-hydroxyphenyl)propanoic acid

C29H40N4O6 (540.29477)


   

Val Leu Tyr Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-4-methylpentanamido]-3-(4-hydroxyphenyl)propanamido]-3-phenylpropanoic acid

C29H40N4O6 (540.29477)


   

Val Pro Tyr Tyr

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-3-(4-hydroxyphenyl)propanamido]-3-(4-hydroxyphenyl)propanoic acid

C28H36N4O7 (540.2583866)


   

Val Tyr Phe Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-(4-hydroxyphenyl)propanamido]-3-phenylpropanamido]-3-methylpentanoic acid

C29H40N4O6 (540.29477)


   

Val Tyr Phe Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-(4-hydroxyphenyl)propanamido]-3-phenylpropanamido]-4-methylpentanoic acid

C29H40N4O6 (540.29477)


   

Val Tyr Ile Phe

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-(4-hydroxyphenyl)propanamido]-3-methylpentanamido]-3-phenylpropanoic acid

C29H40N4O6 (540.29477)


   

Val Tyr Leu Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-(4-hydroxyphenyl)propanamido]-4-methylpentanamido]-3-phenylpropanoic acid

C29H40N4O6 (540.29477)


   

Val Tyr Pro Tyr

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-(4-hydroxyphenyl)propanoyl]pyrrolidin-2-yl]formamido}-3-(4-hydroxyphenyl)propanoic acid

C28H36N4O7 (540.2583866)


   

Val Tyr Tyr Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-methylbutanamido]-3-(4-hydroxyphenyl)propanamido]-3-(4-hydroxyphenyl)propanoyl]pyrrolidine-2-carboxylic acid

C28H36N4O7 (540.2583866)


   

Trp Ala His Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]propanamido]-3-(1H-imidazol-4-yl)propanamido]hexanoic acid

C26H36N8O5 (540.2808526)


   

Trp Ala His Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]propanamido]-3-(1H-imidazol-4-yl)propanamido]-4-carbamoylbutanoic acid

C25H32N8O6 (540.2444691999999)


   

Trp Ala Lys His

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]propanamido]hexanamido]-3-(1H-imidazol-4-yl)propanoic acid

C26H36N8O5 (540.2808526)


   

Trp Ala Gln His

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]propanamido]-4-carbamoylbutanamido]-3-(1H-imidazol-4-yl)propanoic acid

C25H32N8O6 (540.2444691999999)


   

Trp His Ala Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-(1H-imidazol-4-yl)propanamido]propanamido]hexanoic acid

C26H36N8O5 (540.2808526)


   

Trp His Ala Gln

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-(1H-imidazol-4-yl)propanamido]propanamido]-4-carbamoylbutanoic acid

C25H32N8O6 (540.2444691999999)


   

Trp His Lys Ala

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-(1H-imidazol-4-yl)propanamido]hexanamido]propanoic acid

C26H36N8O5 (540.2808526)


   

Trp His Gln Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-3-(1H-imidazol-4-yl)propanamido]-4-carbamoylbutanamido]propanoic acid

C25H32N8O6 (540.2444691999999)


   

Trp Lys Ala His

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]hexanamido]propanamido]-3-(1H-imidazol-4-yl)propanoic acid

C26H36N8O5 (540.2808526)


   

Trp Lys His Ala

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]hexanamido]-3-(1H-imidazol-4-yl)propanamido]propanoic acid

C26H36N8O5 (540.2808526)


   

Trp Gln Ala His

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-4-carbamoylbutanamido]propanamido]-3-(1H-imidazol-4-yl)propanoic acid

C25H32N8O6 (540.2444691999999)


   

Trp Gln His Ala

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-indol-3-yl)propanamido]-4-carbamoylbutanamido]-3-(1H-imidazol-4-yl)propanamido]propanoic acid

C25H32N8O6 (540.2444691999999)


   

Tyr Cys Lys Lys

(2S)-6-amino-2-[(2S)-6-amino-2-[(2R)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-sulfanylpropanamido]hexanamido]hexanoic acid

C24H40N6O6S (540.27299)


   

Tyr Phe Ile Val

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-phenylpropanamido]-3-methylpentanamido]-3-methylbutanoic acid

C29H40N4O6 (540.29477)


   

Tyr Phe Leu Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-phenylpropanamido]-4-methylpentanamido]-3-methylbutanoic acid

C29H40N4O6 (540.29477)


   

Tyr Phe Val Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-phenylpropanamido]-3-methylbutanamido]-3-methylpentanoic acid

C29H40N4O6 (540.29477)


   

Tyr Phe Val Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-phenylpropanamido]-3-methylbutanamido]-4-methylpentanoic acid

C29H40N4O6 (540.29477)


   

Tyr Ile Phe Val

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-methylpentanamido]-3-phenylpropanamido]-3-methylbutanoic acid

C29H40N4O6 (540.29477)


   

Tyr Ile Val Phe

(2S)-2-[(2S)-2-[(2S,3S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-methylpentanamido]-3-methylbutanamido]-3-phenylpropanoic acid

C29H40N4O6 (540.29477)


   

Tyr Lys Cys Lys

(2S)-6-amino-2-[(2R)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]hexanamido]-3-sulfanylpropanamido]hexanoic acid

C24H40N6O6S (540.27299)


   

Tyr Lys Lys Cys

(2R)-2-[(2S)-6-amino-2-[(2S)-6-amino-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]hexanamido]hexanamido]-3-sulfanylpropanoic acid

C24H40N6O6S (540.27299)


   

Tyr Leu Phe Val

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-4-methylpentanamido]-3-phenylpropanamido]-3-methylbutanoic acid

C29H40N4O6 (540.29477)


   

Tyr Leu Val Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-4-methylpentanamido]-3-methylbutanamido]-3-phenylpropanoic acid

C29H40N4O6 (540.29477)


   

Tyr Pro Val Tyr

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanamido]-3-(4-hydroxyphenyl)propanoic acid

C28H36N4O7 (540.2583866)


   

Tyr Pro Tyr Val

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]pyrrolidin-2-yl]formamido}-3-(4-hydroxyphenyl)propanamido]-3-methylbutanoic acid

C28H36N4O7 (540.2583866)


   

Tyr Val Phe Ile

(2S,3S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-methylbutanamido]-3-phenylpropanamido]-3-methylpentanoic acid

C29H40N4O6 (540.29477)


   

Tyr Val Phe Leu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-methylbutanamido]-3-phenylpropanamido]-4-methylpentanoic acid

C29H40N4O6 (540.29477)


   

Tyr Val Ile Phe

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-methylbutanamido]-3-methylpentanamido]-3-phenylpropanoic acid

C29H40N4O6 (540.29477)


   

Tyr Val Leu Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-methylbutanamido]-4-methylpentanamido]-3-phenylpropanoic acid

C29H40N4O6 (540.29477)


   

Tyr Val Pro Tyr

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-methylbutanoyl]pyrrolidin-2-yl]formamido}-3-(4-hydroxyphenyl)propanoic acid

C28H36N4O7 (540.2583866)


   

Tyr Val Tyr Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-methylbutanamido]-3-(4-hydroxyphenyl)propanoyl]pyrrolidine-2-carboxylic acid

C28H36N4O7 (540.2583866)


   

Tyr Tyr Pro Val

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-(4-hydroxyphenyl)propanoyl]pyrrolidin-2-yl]formamido}-3-methylbutanoic acid

C28H36N4O7 (540.2583866)


   

Tyr Tyr Val Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(4-hydroxyphenyl)propanamido]-3-(4-hydroxyphenyl)propanamido]-3-methylbutanoyl]pyrrolidine-2-carboxylic acid

C28H36N4O7 (540.2583866)


   

TPPVQ

Thr-Pro-Pro-Val-Gln

C24H40N6O8 (540.290748)


   

KHAVS

Lys-His-Ala-Val-Ser

C23H40N8O7 (540.3019810000001)


   

17-α, 21-dihydroxy-11,20-dioxo-5-β-pregnan-3-α-yl-β-d-glucuronide

17-α, 21-dihydroxy-11,20-dioxo-5-β-pregnan-3-α-yl-β-d-glucuronide

C27H40O11 (540.257049)


   

(7E)-(3S)-6,19-epidioxy-26,26,26,27,27,27-hexafluoro-9,10-seco-5(10),7-cholestadiene-3,25-diol

6,19-epidioxy-26,26,26,27,27,27-hexafluoro-25-hydroxy-6,19-dihydrovitamin D3 / 6,19-epidioxy-26,26,26,27,27,27-hexafluoro-25-hydroxy-6,19-dihydrocholecalciferol

C27H38F6O4 (540.2674139999999)


   

(5Z,7E)-(1S,3R,23S)-26,26,26,27,27,27-hexafluoro-9,10-seco-5,7,10(19)-cholestatriene-1,3,23,25-tetrol

(23S)-26,26,26,27,27,27-hexafluoro-1α,23,25-trihydroxyvitamin D3 / (23S)-26,26,26,27,27,27-hexafluoro-1α,23,25-trihydroxycholecalciferol

C27H38F6O4 (540.2674139999999)


   

Tetrahydroaldosterone-3-glucuronide

(3alpha,5beta,11beta)-11,18-Epoxy-18,21-dihydro-20-oxopregnan-3-yl-beta-delta-glucopyranosiduronic acid

C27H40O11 (540.257049)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

   

TMC-1D

(2E)-N-[(3S,4R)-3,4-dihydroxy-3-[(1E,3E,5E)-7-[(2-hydroxy-5-oxocyclopenten-1-yl)amino]-7-oxohepta-1,3,5-trienyl]-6-oxocyclohexen-1-yl]-4,6-dimethyldec-2-enamide

C30H40N2O7 (540.283537)


A polyene antibiotic that is TMC-1A in which the 2,4-dimethyloct-2-enoyl group has been replaced by an (E)-4,6-dimethyldec-2-enoyl group. TMC-1D is an antitumour antibiotic isolated from Streptomyces sp. A-230.

   

6,19-epidioxy-26,26,26,27,27,27-hexafluoro-25-hydroxy-6,19-dihydrovitamin D3

(7E)-(3S)-6,19-epidioxy-26,26,26,27,27,27-hexafluoro-9,10-seco-5(10),7-cholestadiene-3,25-diol

C27H38O4F6 (540.267414)


   

(23S)-26,26,26,27,27,27-hexafluoro-1alpha,23,25-trihydroxyvitamin D3

(5Z,7E)-(1S,3R,23S)-26,26,26,27,27,27-hexafluoro-9,10-seco-5,7,10(19)-cholestatriene-1,3,23,25-tetrol

C27H38O4F6 (540.267414)


   

Petromylidene A

2-(E)-(3-methylbutylidene)-7alpha,12alpha,24-trihydroxy-5alpha-cholan-3-one-24-sulfate

C29H48O7S (540.3120577999999)


   

ST 21:2;O5;GlcA

(2S,3S,4R,5R,6R)-3,4,5-trihydroxy-6-{[(2S,14S,16S)-18-hydroxy-2-(2-hydroxyacetyl)-14-methyl-17-oxapentacyclo[14.2.1.0^{1,5}.0^{6,15}.0^{9,14}]nonadecan-11-yl]oxy}oxane-2-carboxylic acid

C27H40O11 (540.257049)


   

2-acetamido-N-[1-[[5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]-4-methylpentanamide,2,2,2-trifluoroacetic acid

2-acetamido-N-[1-[[5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]-4-methylpentanamide,2,2,2-trifluoroacetic acid

C22H39F3N6O6 (540.288303)


   

Atorvastatin lactone

Atorvastatin lactone

C33H33FN2O4 (540.242423)


Atorvastatin lactone is a proagent form of atorvastatin. Atorvastatin is an orally active 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor[1].

   

3,4,5,6-TETRAKIS(BENZYLOXY)-1,2-CYCLOHEXANEDIOL

3,4,5,6-TETRAKIS(BENZYLOXY)-1,2-CYCLOHEXANEDIOL

C34H36O6 (540.2511756)


   

2,3,4,6-tetra-o-benzyl-d-galactopyranose

2,3,4,6-tetra-o-benzyl-d-galactopyranose

C34H36O6 (540.2511756)


   

2,7-Bis(4-ethylphenyl)-4,9-diphenylpyrido[2,3-g]quinoline

2,7-Bis(4-ethylphenyl)-4,9-diphenylpyrido[2,3-g]quinoline

C40H32N2 (540.2565352)


   

2,3,4,6-tetra-o-benzyl-alpha-d-mannopyranose

2,3,4,6-tetra-o-benzyl-alpha-d-mannopyranose

C34H36O6 (540.2511756)


   

taurohyodeoxycholic acid sodium salt

taurohyodeoxycholic acid sodium salt

C26H47NNaO7S+ (540.2970772)


   

2,3,4,6-Tetra-O-benzyl-D-glucopyranose

2,3,4,6-Tetra-O-benzyl-D-glucopyranose

C34H36O6 (540.2511756)


   

1,2,3,4-TETRABENZYL-BETA-D-GLUCOPYRANOSE

1,2,3,4-TETRABENZYL-BETA-D-GLUCOPYRANOSE

C34H36O6 (540.2511756)


   

dinonylnaphthalenedisulfonic acid

dinonylnaphthalenedisulfonic acid

C28H44O6S2 (540.2579164)


   

9,10-Bis[phenyl(m-tolyl)-amino]anthracene

9,10-Bis[phenyl(m-tolyl)-amino]anthracene

C40H32N2 (540.2565352)


   

2,3,4,6-Tetrakis-O-(phenylmethyl)-L-mannose

2,3,4,6-Tetrakis-O-(phenylmethyl)-L-mannose

C34H36O6 (540.2511756)


   

3-O-(2E ,4Z-decadienoyl)-20-O-acetylingenol

3-O-(2E ,4Z-decadienoyl)-20-O-acetylingenol

C32H44O7 (540.3086874)


   

(2S,3R,4S,5S,6R)-3,4,5-tris(phenylmethoxy)-6-(phenylmethoxymethyl)oxan-2-ol

(2S,3R,4S,5S,6R)-3,4,5-tris(phenylmethoxy)-6-(phenylmethoxymethyl)oxan-2-ol

C34H36O6 (540.2511756)


   
   

N-[2-[[[[1-Methyl-5-[(triphenylmethyl)amino]-1H-pyrazol-4-yl]amino]carbonyl]amino]ethyl]carbamic acid tert-butyl ester

N-[2-[[[[1-Methyl-5-[(triphenylmethyl)amino]-1H-pyrazol-4-yl]amino]carbonyl]amino]ethyl]carbamic acid tert-butyl ester

C31H36N6O3 (540.2848746)


   

hydroxypivalyl hydroxypivalate

hydroxypivalyl hydroxypivalate

C28H44O10 (540.2934324)


   

Desfluoroatorvastatin

Desfluoroatorvastatin

C33H36N2O5 (540.2624086)


   

Forskoditerpenoside E

Forskoditerpenoside E

C28H44O10 (540.2934324)


A diterpene glycoside that is labd-14-en-11-one substituted by beta-acetoxy group at position 6, an epoxy group between positions 8 and 13 and a beta-D-glucopyranosyloxy group at position 1 (the 1alpha stereoisomer). Isolated from the whole plant of Coleus forskohlii, it shows relaxative effects on isolated guinea pig tracheal spirals in vitro.

   

26,26,26,27,27,27-hexafluoro-1alpha,23(S),25-trihydroxyvitamin D3

26,26,26,27,27,27-hexafluoro-1alpha,23(S),25-trihydroxyvitamin D3

C27H38F6O4 (540.2674139999999)


   

(2S)-2-amino-N-[[(2S,10R,12S)-12,19-dihydroxy-7,18-dimethoxy-6,17,21-trimethyl-5,8-dioxo-11,21-diazapentacyclo[11.7.1.02,11.04,9.015,20]henicosa-4(9),6,15(20),16,18-pentaen-10-yl]methyl]propanamide

(2S)-2-amino-N-[[(2S,10R,12S)-12,19-dihydroxy-7,18-dimethoxy-6,17,21-trimethyl-5,8-dioxo-11,21-diazapentacyclo[11.7.1.02,11.04,9.015,20]henicosa-4(9),6,15(20),16,18-pentaen-10-yl]methyl]propanamide

C28H36N4O7 (540.2583866)


   

PA(2:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4))

PA(2:0/22:6(5Z,7Z,10Z,13Z,16Z,19Z)-OH(4))

C27H41O9P (540.2488066)


   

PA(2:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7))

PA(2:0/22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7))

C27H41O9P (540.2488066)


   

PA(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/2:0)

PA(22:6(4Z,8Z,10Z,13Z,16Z,19Z)-OH(7)/2:0)

C27H41O9P (540.2488066)


   

PA(2:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14))

PA(2:0/22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14))

C27H41O9P (540.2488066)


   

PA(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/2:0)

PA(22:6(4Z,7Z,10Z,12E,16Z,19Z)-OH(14)/2:0)

C27H41O9P (540.2488066)


   

PA(2:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17))

PA(2:0/22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17))

C27H41O9P (540.2488066)


   

PA(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/2:0)

PA(22:6(4Z,7Z,10Z,13E,15E,19Z)-OH(17)/2:0)

C27H41O9P (540.2488066)


   

PA(2:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17))

PA(2:0/22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17))

C27H41O9P (540.2488066)


   

PA(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/2:0)

PA(22:5(4Z,7Z,10Z,13Z,19Z)-O(16,17)/2:0)

C27H41O9P (540.2488066)


   

Malyngamide B

Malyngamide B

C28H45ClN2O6 (540.296598)


A natural product found in Lyngbya majuscula.

   

Klymollin H

Klymollin H

C27H40O11 (540.257049)


An eunicellin diterpenoid isolated from the soft coral Klyxum molle.

   

S-[2-({N-[(2R)-2-hydroxy-3,3-dimethyl-4-(phosphonooxy)butanoyl]-beta-alanyl}amino)ethyl] dodecanethioate

S-[2-({N-[(2R)-2-hydroxy-3,3-dimethyl-4-(phosphonooxy)butanoyl]-beta-alanyl}amino)ethyl] dodecanethioate

C23H45N2O8PS (540.26341)


   

(+)-(7S,8S,8R,8S)-4,4-dihydroxy-3,3,3,5-tetramethoxy-4,8-oxy-8,8-sesquineolignan-7-ol

(+)-(7S,8S,8R,8S)-4,4-dihydroxy-3,3,3,5-tetramethoxy-4,8-oxy-8,8-sesquineolignan-7-ol

C31H40O8 (540.2723040000001)


A neolignan isolated from the barks of Machilus robusta.

   

8-[1-[4-(Dimethylamino)phenyl]-3-(3-methyl-1-piperidinyl)propyl]-5,7-dimethoxy-4-phenyl-1-benzopyran-2-one

8-[1-[4-(Dimethylamino)phenyl]-3-(3-methyl-1-piperidinyl)propyl]-5,7-dimethoxy-4-phenyl-1-benzopyran-2-one

C34H40N2O4 (540.298792)


   

1-(2-Methoxyphenyl)-3-[4-[[4-[(2-methoxyphenyl)carbamothioylamino]cyclohexyl]methyl]cyclohexyl]thiourea

1-(2-Methoxyphenyl)-3-[4-[[4-[(2-methoxyphenyl)carbamothioylamino]cyclohexyl]methyl]cyclohexyl]thiourea

C29H40N4O2S2 (540.259254)


   

Heptacyclo[31.3.1.1(3,7).1(9,13).1(15,19).1(21,25).1(27,31)]dotetraconta-1(37),3(42),4,6,9(41),10,12,15(40),16,18,21(39),22,24,27(38),28,30,33,35-octadecaene

Heptacyclo[31.3.1.1(3,7).1(9,13).1(15,19).1(21,25).1(27,31)]dotetraconta-1(37),3(42),4,6,9(41),10,12,15(40),16,18,21(39),22,24,27(38),28,30,33,35-octadecaene

C42H36 (540.2816856)


   

1-[(2S,3R)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-fluorophenyl)urea

1-[(2S,3R)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-fluorophenyl)urea

C30H41FN4O4 (540.3111678)


   

N-[[(10R,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylpyridine-4-carboxamide

N-[[(10R,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylpyridine-4-carboxamide

C32H36N4O4 (540.2736416)


   

N-[[(10S,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylpyridine-4-carboxamide

N-[[(10S,11R)-13-[(2R)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylpyridine-4-carboxamide

C32H36N4O4 (540.2736416)


   

N-[[(10S,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylpyridine-4-carboxamide

N-[[(10S,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylpyridine-4-carboxamide

C32H36N4O4 (540.2736416)


   

1-[(2R,3S)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-(4-fluorophenyl)urea

1-[(2R,3S)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-(4-fluorophenyl)urea

C30H41FN4O4 (540.3111678)


   

1-[(2S,3R)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-(4-fluorophenyl)urea

1-[(2S,3R)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-(4-fluorophenyl)urea

C30H41FN4O4 (540.3111678)


   

1-[(2S,3R)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-propan-2-ylurea

1-[(2S,3R)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-propan-2-ylurea

C29H40N4O6 (540.29477)


   

1-[(2R,3S)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-propan-2-ylurea

1-[(2R,3S)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-propan-2-ylurea

C29H40N4O6 (540.29477)


   

1-[(2S,3S)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-propan-2-ylurea

1-[(2S,3S)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-propan-2-ylurea

C29H40N4O6 (540.29477)


   

N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(methylsulfonyl)amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-(4-morpholinyl)propanamide

N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(methylsulfonyl)amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-(4-morpholinyl)propanamide

C25H40N4O7S (540.261757)


   

1-[(2R,3R)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-propan-2-ylurea

1-[(2R,3R)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-propan-2-ylurea

C29H40N4O6 (540.29477)


   

N-[[(10R,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylpyridine-4-carboxamide

N-[[(10R,11S)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylpyridine-4-carboxamide

C32H36N4O4 (540.2736416)


   

N-[[(10S,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylpyridine-4-carboxamide

N-[[(10S,11S)-13-[(2R)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylpyridine-4-carboxamide

C32H36N4O4 (540.2736416)


   

(1R)-1-(benzenesulfonyl)-1-(hydroxymethyl)-7-methoxy-9-methyl-N-propyl-2-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]carboxamide

(1R)-1-(benzenesulfonyl)-1-(hydroxymethyl)-7-methoxy-9-methyl-N-propyl-2-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]carboxamide

C28H36N4O5S (540.2406286)


   

1-[(1R)-1-(hydroxymethyl)-7-methoxy-2-[(4-methoxyphenyl)methyl]-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]-2-pyridin-4-ylethanone

1-[(1R)-1-(hydroxymethyl)-7-methoxy-2-[(4-methoxyphenyl)methyl]-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,4-piperidine]yl]-2-pyridin-4-ylethanone

C32H36N4O4 (540.2736416)


   

1-[(2R,3S)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-fluorophenyl)urea

1-[(2R,3S)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-fluorophenyl)urea

C30H41FN4O4 (540.3111678)


   

1-[(2R,3R)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-(4-fluorophenyl)urea

1-[(2R,3R)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-(4-fluorophenyl)urea

C30H41FN4O4 (540.3111678)


   

N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(methylsulfonyl)amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-(4-morpholinyl)propanamide

N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl(methylsulfonyl)amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-(4-morpholinyl)propanamide

C25H40N4O7S (540.261757)


   

1-[(2S,3S)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-(4-fluorophenyl)urea

1-[(2S,3S)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-(4-fluorophenyl)urea

C30H41FN4O4 (540.3111678)


   

1-[(2S,3R)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-(4-fluorophenyl)urea

1-[(2S,3R)-2-[[cyclohexylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-(4-fluorophenyl)urea

C30H41FN4O4 (540.3111678)


   

1-[(2R,3R)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-propan-2-ylurea

1-[(2R,3R)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-propan-2-ylurea

C29H40N4O6 (540.29477)


   

1-[(2R,3S)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-propan-2-ylurea

1-[(2R,3S)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-propan-2-ylurea

C29H40N4O6 (540.29477)


   

1-[(2S,3R)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-propan-2-ylurea

1-[(2S,3R)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-3-propan-2-ylurea

C29H40N4O6 (540.29477)


   

(2R,3S)-8-[3-(dimethylamino)prop-1-ynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

(2R,3S)-8-[3-(dimethylamino)prop-1-ynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C33H40N4O3 (540.310025)


   

(2R,3S)-8-[3-(dimethylamino)prop-1-ynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

(2R,3S)-8-[3-(dimethylamino)prop-1-ynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenylphenyl)methyl]amino]methyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-6-one

C33H40N4O3 (540.310025)


   

N-[[(10S,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylpyridine-4-carboxamide

N-[[(10S,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylpyridine-4-carboxamide

C32H36N4O4 (540.2736416)


   

N-[[(10R,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylpyridine-4-carboxamide

N-[[(10R,11R)-13-[(2S)-1-hydroxypropan-2-yl]-11,16-dimethyl-14-oxo-9-oxa-13,16-diazatetracyclo[13.7.0.02,7.017,22]docosa-1(15),2,4,6,17,19,21-heptaen-10-yl]methyl]-N-methylpyridine-4-carboxamide

C32H36N4O4 (540.2736416)


   

(1S)-1-(benzenesulfonyl)-1-(hydroxymethyl)-7-methoxy-9-methyl-N-propyl-2-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]carboxamide

(1S)-1-(benzenesulfonyl)-1-(hydroxymethyl)-7-methoxy-9-methyl-N-propyl-2-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]carboxamide

C28H36N4O5S (540.2406286)


   
   

4,6-dideoxy-4-(3-deoxy-L-glycero-tetronamido)-alpha-D-Manp2Me-(1->2)-4,6-dideoxy-4-(3-deoxy-L-glycero-tetronamido)-alpha-D-ManpOMe

4,6-dideoxy-4-(3-deoxy-L-glycero-tetronamido)-alpha-D-Manp2Me-(1->2)-4,6-dideoxy-4-(3-deoxy-L-glycero-tetronamido)-alpha-D-ManpOMe

C22H40N2O13 (540.253027)


   

[1-propanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate

[1-propanoyloxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypropan-2-yl] (4Z,7Z,10Z,13Z)-hexadeca-4,7,10,13-tetraenoate

C28H44O10 (540.2934324)


   

[1-Hydroxy-3-[hydroxy-(3-hydroxy-2-propanoyloxypropoxy)phosphoryl]oxypropan-2-yl] hexadecanoate

[1-Hydroxy-3-[hydroxy-(3-hydroxy-2-propanoyloxypropoxy)phosphoryl]oxypropan-2-yl] hexadecanoate

C25H49O10P (540.3063184)


   

[1-[(2-Acetyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] heptadecanoate

[1-[(2-Acetyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] heptadecanoate

C25H49O10P (540.3063184)


   

[1-[(2-Heptanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] dodecanoate

[1-[(2-Heptanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] dodecanoate

C25H49O10P (540.3063184)


   

[1-[(2-Butanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] pentadecanoate

[1-[(2-Butanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] pentadecanoate

C25H49O10P (540.3063184)


   

[1-Hydroxy-3-[hydroxy-(3-hydroxy-2-pentanoyloxypropoxy)phosphoryl]oxypropan-2-yl] tetradecanoate

[1-Hydroxy-3-[hydroxy-(3-hydroxy-2-pentanoyloxypropoxy)phosphoryl]oxypropan-2-yl] tetradecanoate

C25H49O10P (540.3063184)


   

[1-Hydroxy-3-[hydroxy-(3-hydroxy-2-octanoyloxypropoxy)phosphoryl]oxypropan-2-yl] undecanoate

[1-Hydroxy-3-[hydroxy-(3-hydroxy-2-octanoyloxypropoxy)phosphoryl]oxypropan-2-yl] undecanoate

C25H49O10P (540.3063184)


   

[1-[(2-Hexanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] tridecanoate

[1-[(2-Hexanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] tridecanoate

C25H49O10P (540.3063184)


   

[1-Hydroxy-3-[hydroxy-(3-hydroxy-2-nonanoyloxypropoxy)phosphoryl]oxypropan-2-yl] decanoate

[1-Hydroxy-3-[hydroxy-(3-hydroxy-2-nonanoyloxypropoxy)phosphoryl]oxypropan-2-yl] decanoate

C25H49O10P (540.3063184)


   

[1-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-nonanoyloxypropan-2-yl] decanoate

[1-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-nonanoyloxypropan-2-yl] decanoate

C25H49O10P (540.3063184)


   

(1-heptanoyloxy-3-phosphonooxypropan-2-yl) (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate

(1-heptanoyloxy-3-phosphonooxypropan-2-yl) (3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoate

C28H45O8P (540.28519)


   

[1-Acetyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] heptadecanoate

[1-Acetyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] heptadecanoate

C25H49O10P (540.3063184)


   

[1-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-pentanoyloxypropan-2-yl] tetradecanoate

[1-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-pentanoyloxypropan-2-yl] tetradecanoate

C25H49O10P (540.3063184)


   

(1-phosphonooxy-3-propanoyloxypropan-2-yl) (7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoate

(1-phosphonooxy-3-propanoyloxypropan-2-yl) (7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoate

C28H45O8P (540.28519)


   

[1-Butanoyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] pentadecanoate

[1-Butanoyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] pentadecanoate

C25H49O10P (540.3063184)


   

[1-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-hexanoyloxypropan-2-yl] tridecanoate

[1-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-hexanoyloxypropan-2-yl] tridecanoate

C25H49O10P (540.3063184)


   

(1-pentanoyloxy-3-phosphonooxypropan-2-yl) (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate

(1-pentanoyloxy-3-phosphonooxypropan-2-yl) (5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoate

C28H45O8P (540.28519)


   

[1-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-heptanoyloxypropan-2-yl] dodecanoate

[1-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-heptanoyloxypropan-2-yl] dodecanoate

C25H49O10P (540.3063184)


   

[1-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-octanoyloxypropan-2-yl] undecanoate

[1-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-octanoyloxypropan-2-yl] undecanoate

C25H49O10P (540.3063184)


   

[1-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-propanoyloxypropan-2-yl] hexadecanoate

[1-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-propanoyloxypropan-2-yl] hexadecanoate

C25H49O10P (540.3063184)


   

Ingenol O-Decaenoyl, O-Ac or isomer putative

Ingenol O-Decaenoyl, O-Ac or isomer putative

C32H44O7 (540.3086874)


   
   

S-dodecanoyl-4-phosphopantetheine

S-dodecanoyl-4-phosphopantetheine

C23H45N2O8PS (540.26341)


An S-acyl-4-phosphopantetheine obtained by formal condensation of the thiol group of D-pantetheine 4-phosphate with the carboxy group of dodecanoic acid.

   

methyl 4,6-dideoxy-4-(3-deoxy-D-glycero-tetronamido)-alpha-D-Manp2Me-(1->2)-4,6-dideoxy-4-(3-deoxy-D-glycero-tetronamido)-alpha-D-Manp

methyl 4,6-dideoxy-4-(3-deoxy-D-glycero-tetronamido)-alpha-D-Manp2Me-(1->2)-4,6-dideoxy-4-(3-deoxy-D-glycero-tetronamido)-alpha-D-Manp

C22H40N2O13 (540.253027)


An amido disaccharide corresponding to the (2R)-2,4-dihydroxybutanoyl diastereomer of the fragment which mimicks the terminus of the O-polysaccharide of Vibrio cholerae O:1, serotype Ogawa.

   
   
   
   

PA P-18:1/7:4;O

PA P-18:1/7:4;O

C28H45O8P (540.28519)